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Preterm birth (PTB; birth before 37 completed weeks of gestation) remains the major
cause of neonatal morbidity and mortality. The current generation of biomarkers
predictive of PTB have limited utility. In pregnancy, the human cervicovaginal fluid (CVF)
proteome is a reflection of the local biochemical milieu and is influenced by the physical
changes occurring in the vagina, cervix and adjacent overlying fetal membranes. Term
and preterm labor (PTL) share common pathways of cervical ripening, myometrial
activation and fetal membranes rupture leading to birth. We therefore hypothesize that
CVF biomarkers predictive of labor may be similar in both the term and preterm labor
setting. In this review, we summarize some of the existing published literature as well
as our team’s breadth of work utilizing the CVF for the discovery and validation of
putative CVF biomarkers predictive of human labor. Our team established an efficient
method for collecting serial CVF samples for optimal 2-dimensional gel electrophoresis
resolution and analysis. We first embarked on CVF biomarker discovery for the prediction
of spontaneous onset of term labor using 2D-electrophoresis and solution array multiple
analyte profiling. 2D-electrophoretic analyses were subsequently performed on CVF
samples associated with PTB. Several proteins have been successfully validated and
demonstrate that these biomarkers are associated with term and PTL and may be
predictive of both term and PTL. In addition, the measurement of these putative
biomarkers was found to be robust to the influences of vaginal microflora and/or semen.
The future development of a multiple biomarker bed-side test would help improve the
prediction of PTB and the clinical management of patients.
Keywords: cervicovaginal fluid, preterm birth, preterm labor, predictive biomarkers, pregnancy, IL-1 receptor
antagonist, thioredoxin, vitamin D binding protein
Introduction
A human pregnancy has a gestational period between 37 and 42 weeks. Births before 37
completed weeks of gestation are classified as preterm. Preterm birth (PTB) remains a
major obstetric complication that leads to an increased risk of adverse neonatal morbidity
and mortality (March of Dimes Foundation, 2009). Currently, the ability to predict PTB
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is disappointing. Biomarkers that can predict PTB with improved
sensitivity and specificity are required. In pregnancy, the human
cervicovaginal fluid (CVF) proteome reflects the biochemical
milieu and physiological changes of the vagina, cervix and
adjacent overlying fetal membranes. Although the initiating
triggers may differ, the physiology of human parturition at term
and preterm gestations share the common pathways of cervical
ripening, myometrial activation and membrane rupture. In this
review, we describe our team’s breadth of work utilizing the
CVF for the discovery and validation of biomarkers predictive
of human labor.
Physiology of Human Labor
Human parturition is characterized by regular and painful
uterine contractions that increase in duration, intensity,
and frequency. With each successive contraction, the fetus
progressively descends and exerts pressure on the cervix and
overlying fetal membranes. This promotes remodeling of the
cervix leading to effacement and dilatation (Rechberger and
Woessner, 1993; Ludmir and Sehdev, 2000), weakening and
rupture of fetal membranes (Moore et al., 2006; Kendal-Wright,
2007) and the subsequent delivery of the neonate. In general,
the spontaneous onset of uterine contractions and cervical
remodeling precede fetal membrane rupture (Norwitz et al.,
1999). However, the spontaneous rupture of the fetal membranes
can also occur in the absence of uterine contractions and/or
cervical dilatation at term and preterm gestations, i.e., pre-labor
rupture of membranes (PROM). PROM may arise from a
different physiological pathway than that of spontaneous term
and preterm labor (PTL; Fortunato and Menon, 2001).
Parturition is a complex systemic physiological event
involving multiple reproductive or gestational tissues (fetal
membranes, uterus, cervix and vagina) and various biochemical
and physical pathways including: hormonal regulation [e.g.,
activation of the fetal hypothalamic-pituitary-adrenal axis
(Challis et al., 2000), progesterone (Mesiano et al., 2002; Challis
et al., 2003), estrogen (Adachi and Oku, 1995) and prostaglandin
(Mitchell et al., 1995; Romero et al., 1996)]; inflammation
(Liggins, 1989; Romero et al., 1989; Thomson et al., 1999;
Ledingham et al., 2000, 2001; Rauk and Chiao, 2000; Haddad
et al., 2006; Osman et al., 2006; Heng et al., 2014a); mechanical
stretch (Kloeck and Jung, 1973; Maehara et al., 1996; Maradny
et al., 1996; Hall et al., 1997; Lyall et al., 2002; Loudon et al.,
2004; Terzidou et al., 2005; Turton et al., 2009); oxidative stress
(Yin and Zhen, 1995; Yoshida et al., 2001; Ekerhovd et al., 2002;
Vaisanen-Tommiska et al., 2003; Burton and Jauniaux, 2010;
Heng et al., 2010a; Chai et al., 2012); apoptosis (Gearing et al.,
1994;Menon et al., 2002;Moore et al., 2002, 2003; El Khwad et al.,
2006; Reti et al., 2007); lipid metabolism (Skannal et al., 1997;
Slater et al., 2004; Farina et al., 2007); and extracellular matrix
(ECM) remodeling (Matrisian, 1992; Myers and Nathanielsz,
1993; Vadillo-Ortega et al., 1995; Xu et al., 2002; Menon and
Fortunato, 2004; Timmons and Mahendroo, 2007; Nishihara
et al., 2008).
Preterm Birth
Globally, approximately 15 million babies are born prematurely
each year. PTB rates are highest (15% or higher) in developing
nations such as Pakistan, Indonesia and sub-Saharan Africa
(World Health Organisation, 2012). In 2010, there were 22,952
PTB out of 297,357 live births (8.3%) in Australia (AIHW
et al., 2012). PTB rates in the United States have reached 12%
and have remained consistently high between 1990 and 2010
(Kuehn, 2012; World Health Organisation, 2012; Martin and
Osterman, 2013). The rising incidence of PTB, especially late
PTB between 34 and 36 weeks of gestation, is thought to be the
result of obstetric complications and the increase in multifetal
pregnancies associated with modern fertility treatments (Ananth
and Vintzileos, 2006).
PTB contributes to the 3.1 million neonatal deaths worldwide
annually (35%) (World Health Organisation, 2012). The survival
rate of premature babies correlates with advancing gestational
age. In England the survival rate for preterm neonates born at
23 weeks is 19% with the rate increasing to 77% if birth occurs at
26 weeks (Costeloe et al., 2012). Although advances in perinatal
care have improved survival rates, cognitive impairment and
other life-long disabilities associated with preterm birth remain
significant (Lorenz, 2001; Greenough et al., 2005; Field et al.,
2008; Moster et al., 2008; Johnson et al., 2009). It is not surprising
that PTB carries an immense financial burden particularly
in developed countries where advanced medical resources are
widely available. Premature babies require a longer hospital
stay, have medical complications necessitating multiple hospital
admissions and the use of medical equipment and operative
procedures (St. John et al., 2000; Petrou, 2005; Gilbert, 2006). The
annual economic cost of PTB is estimated at USD$26 billion in
the United States (Institute of Medicine, 2007) and £3 billion in
the United Kingdom (Mangham et al., 2009).
PTB can be categorized as either spontaneous or iatrogenic.
About 75% of PTB are spontaneous, resulting from spontaneous
PTL with intact membranes (45%) or spontaneous preterm
pre-labor rupture of fetal membranes (preterm PROM; 30%).
The remaining 25% of PTB are iatrogenic due to maternal
(e.g., diabetes), placental (e.g., pre-eclampsia) or fetal disorders
(e.g., intra-uterine growth restriction) that necessitate delivery
of a compromised fetus and/or mother (Moutquin, 2003; Steer,
2006).
The etiology of PTB is multifactorial. Multiple pregnancy,
previous PTB, ethnicity (especially of African descent, Zhang
and Savitz, 1992; Adams et al., 2000) and second- or third-
trimester vaginal bleeding are most consistently associated
with PTB. Other factors associated with the initiation of
PTL include: poor maternal sociobiological variables (stress,
malnutrition, smoking, low socioeconomic status, heavy
physical work and substance abuse); fetal physiological stress
(malformation, intra-uterine growth restriction); infection;
preterm PROM; cervical dysfunction; placental abruption;
uterine over distension (polyhydramnios or multifetal gestation);
and genetic predisposition (familial factors and geneticmutation)
(Hall et al., 1997; Mercer et al., 1999; Genç et al., 2002; Lockwood,
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2003; Goffinet, 2005; Oyelese and Ananth, 2006; Steer, 2006;
Holst and Garnier, 2008).
The treatment of PTL involves the use of tocolytic agents
(e.g., β-adrenergic receptor agonists such as ritodrine or
calcium channel blockers such as nifedipine) to inhibit uterine
contractions (Barden et al., 1980; Ulmsten et al., 1980). Tocolytics
may stop contractions temporarily but rarely prevent PTB
(Goldenberg, 2002). Thus, the current application of tocolytics
is largely directed at prolonging the pregnancy for up to 48 h
to augment fetal lung maturity after maternal corticosteroid
administration and arrange transport of the woman to a tertiary
hospital with appropriate neonatal facilities (Lyndon, 2006).
The prevention of PTB in women with known risk factors may
be divided into two approaches: (i) to reduce clinical risk factors
by antenatal education (e.g., optimal nutrition, McGregor et al.,
2001; Carlson et al., 2013) and reducing physical and emotional
stress and substance abuse; and (ii) optimize appropriate use
of pharmacological agents such as the use of progesterone.
Progesterone has been clinically trialed to prevent PTB with
encouraging results (reviewed by Iams, 2014). The prevention
of PTB is more challenging for women in their first pregnancy
who have no known risk factors. For all women, screening
programs to detect early cervical change by ultrasonography
are of limited benefit. Alternatively, diagnostic screening tools
(biochemical markers) to reliably predict the onset of (preterm)
labor (Goldenberg, 2002) are required. The prognostic value of
the current biochemical markers to predict PTB is disappointing.
The relatively poor sensitivity and positive predictive value of
these tests often lead to costly and unnecessary interventions.
Predicting Human Labor
Given the challenges of preventing PTB, the ability to reliably
predict who will deliver preterm may aid in the clinical
management of asymptomatic or symptomatic women (i.e.,
in threatened PTL with uterine contractions without cervical
dilatation). The accurate prediction of PTL is difficult due to
the multifactorial etiology of PTB as various biochemical triggers
may result in different clinical presentations of early onset labor.
Therefore, a single predictor of PTB may yield varying utility in
symptomatic women compared to asymptomatic womenwithout
or with risk factors for PTL (e.g., previous history of PTB or
preterm PROM,multifetal gestation, cervical incompetence etc.).
Risk Scoring
Risk scoring is a quantitative approach to identify women
as low-, medium-, or high-risk for PTB within the obstetric
population (Krupa et al., 2006). A combined Australia and New
Zealand cohort study of nulliparous women reported maternal
demographics (ethnicity, low body mass index, smoking, drug
use, and anxiety) and obstetric characteristics (>3 months to
conceive, shortened cervical length, gestational diabetes, mild
gestational hypertension and preeclampsia) as risk factors for
spontaneous PTB and/or preterm PROM (Dekker et al., 2012).
Other factors associated with a higher risk of PTB include
multifetal gestation (Martin et al., 2012), bacterial vaginosis
(Guaschino et al., 2006) and previous cervical cone biopsy (Raio
et al., 1997). However the use of risk scoring alone is often
unreliable as more than 50% of women who experience PTB have
no recognizable risk factor (Mercer et al., 1999; Shankar et al.,
2005; Dekker et al., 2012).
Cervical Length
Transvaginal ultrasonography was introduced in the 1980s as
a screening tool to assess the cervical morphology during
pregnancy (measurement of cervical length and evaluate the
dilated internal cervical os, Okitsu et al., 1992; Leitich, 2005). It
is a more reliable and reproducible method than digital cervical
examination to predict PTB (Krupa et al., 2006). A study by
Iams et al. (1996) reported increasing risk of PTB (<35 weeks of
gestation) in asymptomatic women as cervical length deceases.
Systematic reviews of asymptomatic women (at <24 weeks of
gestation) found that a cervical length <25mm is associated
with PTB before 35 weeks of gestation, with positive likelihood
ratios (LR+) ranging from 2.8 to 6.3 (Honest et al., 2003; Crane
and Hutchens, 2008); and that a range of cut-off values for
cervical length (25–35mm) achieved 33–54% sensitivity and
73–91% specificity to predict PTB (Leitich et al., 1999a). The
low sensitivity afforded by cervical ultrasonography limits this
method as a routine screening test in low-risk asymptomatic
women (Resnik, 2005).
In symptomatic women, a cervical length <15mm yields a
LR+ of 8.7 for preterm delivery within 7 days, compared to a
LR+ of 0.4 when the cervical length is ≥15mm (Gomez et al.,
2005). Berghella et al. (2013) found that knowledge of cervical
length was associated with a non-significant decrease (22.3%) in
the incidence of PTB before 37 weeks in symptomatic women,
compared to when the cervical length was not known (34.7%).
Thus, the authors did not recommend the use of transvaginal
ultrasonography as a routine screening tool.
Biochemical Markers
Biological fluids including amniotic fluid, urine,
serum/plasma/whole blood, saliva and CVF provide rich
sources of proteins and molecules which are significantly altered
in response to different biological states (Darne et al., 1987;
Romero et al., 1989; Agrez et al., 1999; Goldenberg et al., 2001; Di
Quinzio et al., 2008; Heng et al., 2014a). In symptomatic women,
fetal fibronectin (fFN) and phosphorylated insulin-like growth
factor binding protein-1 (phIGFBP1) bedside test kits utilizing
CVF are currently used to predict PTB. However, no current
single biomarker can positively predict PTB reliably in either
asymptomatic or symptomatic women.
Fetal Fibronectin
The fFN test is more commonly used to predict PTB in
symptomatic women with threatened PTL but has also been
investigated in asymptomatic pregnant women. fFN is a 450 kDa
glycoprotein secreted by trophoblasts in the fetal membranes
whichmaintains the integrity of the ECM at the interface between
the fetal chorion and maternal decidua (Sibille et al., 1986). It
is generally not detectable in the CVF of women after 16 to 20
weeks of gestation. The detection of fFN between 22 and 34 weeks
of gestation may signify the premature detachment of the fetal
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chorion from thematernal decidua (Sibille et al., 1986; Lockwood
et al., 1991). The pioneering study by Lockwood et al. (1991)
described the clinical utility of fFN to predict spontaneous PTB
in symptomatic women (n = 117 women) with 81.7% sensitivity,
82.5% specificity, 83.1% positive predictive value (PPV), and
81.0% negative predictive value (NPV), based on a fFN threshold
concentration of ≥50 ng/mL.
In asymptomatic women, fFN has low sensitivity (20–29%)
and poor PPV (17–25%) to predict PTB at <34 weeks of
gestation; but the NPV remains high (96–97%) (Goldenberg
et al., 1996). A subsequent meta-analysis by Leitich et al. (1999b)
of asymptomatic women reported a sensitivity of 22% but
comparable specificity of 97% of fFN to predict spontaneous PTB
within seven days. By contrast, in symptomatic women, meta-
analyses performed by Sanchez-Ramos et al. (2009) and Boots
et al. (2014) reported improved predictive utility of fFN with
75–76% sensitivity and 79–82% specificity to predict PTB within
7 days.
Fetal fibronectin testing may not be feasible in up to
50% of women due to recent vaginal digital examination,
unprotected sexual intercourse, vaginal bleeding or amniotic
fluid contamination from the rupture of fetal membranes as
these may cause a false positive result (Sadovsky and Friedman,
1992; Shimoya et al., 1998). Thus, the poor sensitivity, relatively
low patient eligibility and false positive results all limit fFN as
a screening tool for PTB. It is now generally accepted that the
fFN test is most clinically useful for its high NPV to predict PTB
within seven to 14 days of sampling (Goldenberg, 2002; Honest
et al., 2002; Ramsey and Andrews, 2003). A recent proposal to
combine cervical length and fFN to screen symptomatic (Hincz
et al., 2002; Schmitz et al., 2006; Dutta and Norman, 2010;
DeFranco et al., 2013) and asymptomatic women (Bolt et al.,
2011; Fox et al., 2012) appears to result in greater sensitivity
and PPV, compared to fFN testing alone, to predict PTB.
Further studies will determine whether this combined screening
approach can be informative for the clinical management of
women in the future.
Phosphorylated Insulin-like Growth Factor Binding
Protein-1
The IGFBP1 test is another commonly used predictive test for
PTL. IGFBP1 is a 25kDa protein that is secreted by maternal
decidual cells as a highly phosphorylated isoform, phIGFBP1
(Rutanen et al., 1985; Westwood et al., 1994; Martina et al., 1997).
The non-phosphorylated form of IGFBP1 is predominately
present in the amniotic fluid (Nuutila et al., 1999). The
concentration of IGFBP1 increases at the beginning of the second
trimester in amniotic fluid and decidua when the amnion fuses
with the choriodecidua (Wathen et al., 1993) and the degree of
phosphorylation increases until late pregnancy (Koistinen et al.,
1993). Like fFN, the detection of phIGFBP1 in the CVF indicates
a disruption of the choriodecidual interface.
phIGFBP1 was first evaluated to diagnose preterm PROM
with high sensitivity and a positive test was associated with a
6.9-fold increased risk of PTB (Rutanen et al., 1996). Kekki
et al. (2001) conducted a study of 63 symptomatic women where
subjects with >10 mg/L of cervical phIGFBP1 had a ten-fold
higher risk of PTB. phIGFBP1 predicts spontaneous PTB in
women with threatened PTL with 69–70% sensitivity, 74–90%
specificity, 48–50% PPV and 88–96% NPV (Paternoster et al.,
2007; Tanir et al., 2009); whilst a meta-analysis reported that
phIGFBP1 predicts PTB in asymptomatic women with a pooled
33% sensitivity, 79% specificity, LR+ of 1.6 and a LR− of 0.8
(Conde-Agudelo et al., 2011).
The phIGFBP1 test has a comparable NPV to the fFN test
in predicting spontaneous PTB within 7 days in symptomatic
women (phIGFBP1 92% vs. fFN 97%) (Ting et al., 2007). In
asymptomatic women, phIGFBP1 and fFN have significantly
different PPVs (phIGFBP1, 0% vs. fFN, 67%) but similar NPVs
(phIGFBP1, 70% vs. fFN, 79%) for predicting PTB (Khambay
et al., 2012). phIGFBP1 is not affected by the presence of seminal
fluid or vaginal bleeding. These studies indicate that, like fFN,
the clinical utility of the phIGFBP1 test, is as a reliable negative
predictor of PTB but thus far no systematic meta-analyses on the
predictive utility of phIGFBP1 have been performed.
Other Biochemical Markers
Given the poor sensitivity of the fFN and phIGFBP1 tests
to predict spontaneous PTB in the asymptomatic pregnant
population, researchers have investigated alternative biomarkers
associated with PTL and assessed their predictive utility. The
evaluation of these putative biomarkers indicates that no single
biomarker is superior in predicting spontaneous PTB (Wei et al.,
2010; Conde-Agudelo et al., 2011; Menon et al., 2011; Bhat et al.,
2013), perhaps reflecting the different aetiologies associated PTL.
The involvement of multiple biochemical pathways associated
with parturition presents a challenge to identify a single
biomarker that reliably predicts human labor. Furthermore,
reproducibility is a common problem encountered by different
biomarker validation studies. Experimental design including
the CVF sampling method, patient selection/exclusion criteria
(e.g., intact vs. ruptured membranes), sample selection/exclusion
criteria, varying sample sizes and different statistical approaches
used in predictive modeling analyses can all affect the
outcome of results. The importance of a well-designed study
with strict patient selection criteria is crucial for a fair
and accurate comparison of putative biomarkers to predict
spontaneous PTB.
Summary of Commonly Used Screening Tests
The advantages and disadvantages of the most commonly used
tests to predict PTL are summarized in Table 1. While risk
scoring can be performed essentially free of cost, extensive
demographic andmedical history data relating to the current and
previous pregnancies is essential. Transvaginal ultrasonography
can often be informative but relies on the availability of expensive
ultrasound equipment and a skilled ultrasonographer to interpret
the information. At best, ultrasound measurements of the cervix
can serve as an adjunct to other screening tests. The biochemical
tests continue to be unreasonably expensive but can provide
valuable reassurance (negative likelihood) particularly for the
symptomatic woman from a remote community where neonatal
intensive care facilities are not available.
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TABLE 1 | Summary of commonly used tests to predict preterm labor.
Method Approach Advantages Disadvantages
Risk scoring Computer-based algorithm to
determine risk
• Essentially “no cost”
• Fairly rapid and easy to perform
• Requires extensive demographic and medical history information
• Poor predictive utility
Cevical length Transvaginal ultrasonography • Can be incorporated during routine
antenatal examination
• Essentially “no additional cost”
• Provides useful information on the
state of the cervix
• Fairly rapid to perform
• Expensive ultrasound equipment required
• Requires skilled ultrasonographer
• Limited predictive utility but may be a useful adjunct to
biochemical tests
Biochemical tests “Dip-stick” tests
Quikcheck (fFN)
Actim partus (phIGFBP1)
• Rapid and easy to perform
• Good negative predictive value
• Moderately expensive analyzer
• Expensive single test
• May be influenced by contaminants (blood, amniotic fluid, semen)
• Semi-quantitative
• Predetermined threshold cut-off
• Poor positive predictive value
Immunoassay
Rapid TLiIQ (fFN)
• Rapid and easy to perform
• Good negative predictive value
• Moderately expensive analyzer
• Expensive single test
• May be influenced by contaminants (blood, amniotic fluid, semen)
• Semi-quantitative
• Predetermined threshold cut-off
• Poor positive predictive value
Immunoassay
Rapid 10Q (fFN)
• Rapid and easy to perform
• Accurate quantification
• Ability to choose the desired
threshold cut-off
• Good negative predictive value
• Moderately expensive analyzer
• Expensive single test
• May be influenced by contaminants (blood, amniotic fluid, semen)
• Poor positive predictive value
Cervicovaginal Fluid Biomarkers of Human
Labor
High throughput proteomic techniques have expanded biological
studies from the biochemical analysis of single proteins to
proteome-wide investigations that have allowed the direct
comparison of novel or differentially expressed proteins to be
made between disease and non-disease states (Colantonio and
Chan, 2005; Monti et al., 2005). Extensive descriptive proteomic
studies of urine (Coon et al., 2008; Zürbig et al., 2009), plasma,
saliva (Yan et al., 2009), lung tissues, bronchoalveolar lavage
(Marko-Varga et al., 2005), amnion, amniotic fluid (Nilsson et al.,
2004; Park et al., 2006; Michaels et al., 2007), placenta (Butt et al.,
2006) and gynecological carcinomas including the ovary (Alaiya
et al., 1999), vagina (Hellman et al., 2004) and cervix (Bae et al.,
2005) have been described. These proteomic maps are catalogs
of the protein complement in a specific tissue or body fluid,
representing the presence and the relative abundance of proteins
at a given point in time (Pennington et al., 1997).
Human CVF is a rich source of proteins and other
metabolites ideal for the discovery of biomarkers associated
with gynecological and pregnancy complications. Human labor
involves cervical remodeling, myometrial activation and rupture
of the fetal membranes. Given that the CVF is largely a product
derived from these gestational tissues, the precise biochemical
mechanisms involved and the timing of these dynamic processes
during labor may be reflected in the CVF. Historically, CVF
proteins have been selectively targeted and studied to predict
labor, such as fFN (Lockwood et al., 1991), IGFBP1 (Kekki
et al., 2001), defensins and lactoferrin (Goldenberg et al.,
2001), sialidase (Andrews et al., 1999; Goldenberg et al., 2001),
granulocyte elastase (Nakai et al., 2005), human chorionic
gonadotropin (Sanchez-Ramos et al., 2003; Garshasbi et al.,
2004), interleukin (IL) 1beta (Tanaka et al., 1998), IL6 (Rizzo
et al., 1996; Coleman et al., 2001; Grenache et al., 2004; Holst
et al., 2005; Woodworth et al., 2007), IL8 (Rizzo et al., 1998;
Tanaka et al., 1998; Holst et al., 2005), IL18 (Jacobsson et al.,
2003), interleukin-1 receptor antagonist (IL1RN) (Rizzo et al.,
1996) and tumor necrosis factor (Rizzo et al., 1996; Grenache
et al., 2004).
Cervicovaginal Fluid Proteome
Our research group was the first to publish the CVF proteome
map of pregnant women utilizing 2-dimensional-polyacrylamide
gel electrophoresis (2D-PAGE) and mass spectrometry (matrix-
assisted laser desorption/ionization time of flight, MALDI-ToF,
or liquid chromatography coupled to an electrospray ion-trap,
LC-ESI-MS/MS). Twenty-one proteins spots were characterized,
yielding 15 different proteins involved in the regulation of
oxidative stress defense, proteolysis and inflammation (Di
Quinzio et al., 2007). A comprehensive CVF proteomic study
by Dasari et al. (2007) was published a few months later. They
identified 150 unique proteins in second trimester pregnant
women using LC-MS/MS and gel electrophoresis. The CVF in
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these two studies was collected using either rayon (Di Quinzio
et al., 2007) or Dacron R© swabs (Dasari et al., 2007) and protein
was later extracted into a solubilization buffer. Four research
papers on the CVF proteome were subsequently published. Tang
et al. (2007) identified and characterized 147 proteins by 2D-
PAGE and MALDI-ToF/ToF in the vaginal lavage from non-
pregnant, non-infected women and validated selected proteins
by immuno-blotting. Shaw and co-workers (Shaw et al., 2007)
collected CVF from healthy non-pregnant women by inserting
a 5 × 5 cm sterile gauze into the vagina and extracting the
fluid into 10mL of PBS; 685 proteins were identified using 1D-
PAGE and strong cation exchange chromatography, followed by
LC-MS/MS. Pereira et al. (2007) identified 205 proteins using
multidimensional protein identification technology (MudPIT)
from CVF collected using Dacron swabs from asymptomatic
controls and symptomatic women admitted in threatened PTL.
Klein et al. (2008) collected CVF samples from women admitted
with symptoms of threatened PTL using vaginal wash (for 2D-
PAGE) and Dacron swabs (for LC-MS/MS) and identified 39
unique proteins.
Whilst these studies (Dasari et al., 2007; Pereira et al., 2007;
Shaw et al., 2007; Tang et al., 2007; Klein et al., 2008) produced
comprehensive proteomic “maps” or “fingerprints,” it is unclear
what proportion of the identified proteins were common to all
women. Work from our laboratory has focused on common
CVF proteins in pregnant women (Di Quinzio et al., 2007, 2008;
Heng et al., 2010b; Liong et al., 2013a,b, 2015). For example,
in our 2007 paper, 2D-PAGE gels were compared between five
pregnant women at term. Although the number of protein spots
visualized in each gel varied from 361 to 484, only about one
third of the protein spots (n = 157) were common to all
five women (Di Quinzio et al., 2007). This may be attributed
to individual biological variation and the non-sterile vaginal
environment. Zegels et al. (2009) analyzed CVF samples obtained
via colposcopy and compared their findings with published CVF
proteomic studies. The large variation of identified proteins
amongst these studies were attributed to biological factors
(menstruation, age, infection, unprotected sexual intercourse,
use of contraceptives, pregnancy etc.), and different sampling
and analytical methods. The creation of a core CVF proteome
reference library may facilitate future research studies.
Proteomic Studies of Preterm Birth
Proteomic technologies have been applied to amniotic fluid in
search of biomarkers of intra-amniotic infection (Gravett et al.,
2004; Buhimschi et al., 2005; Rüetschi et al., 2005; Bujold et al.,
2008), PTB (Romero et al., 2010; Fotopoulou et al., 2012) and
preterm PROM (Vuadens et al., 2003; Wang et al., 2011; Tambor
et al., 2012); in the placentae for preterm PROM (Chang et al.,
2013), in the serum for PTB (Pereira et al., 2010; Esplin et al.,
2011) and recently, in leukocyte lysates for PTB (Heng et al.,
2015). Studies of the CVF proteome in association with PTB
have been reviewed by Zegels et al. (2010). One of the first
CVF discovery studies for PTB identified an increased expression
of bactenecin-1 in the CVF of sheep after fetal glucocorticoid-
induced PTL (Young et al., 2007). There have been eight
subsequent discovery-based studies of human CVF, including
five from our group, that have explored proteomic changes in
association with spontaneous term labor (Di Quinzio et al., 2008;
Heng et al., 2010b), PTL (Pereira et al., 2007; Shah et al., 2009;
Liong et al., 2013a, 2015; Lo et al., 2014) or preterm PROM (Liong
et al., 2013b).
Pereira et al. (2007) compared the CVF proteome between
three groups of women: symptomatic women admitted with
threatened PTL who delivered preterm, symptomatic women in
“false” labor who delivered at term and asymptomatic gestation-
matched controls. They reported 28 (using MudPIT analysis)
and 17 (using two-dimensional difference in gel electrophoresis,
2D-DIGE) significantly altered proteins, including annexin A3,
annexin V, cystatin A, profilin 1, group-specific component
(vitamin D binding protein) and IGFBP1 fragments (16 and
11 kDa). Western blot validated the differential expression of
calgranulin A and B, annexin V, profilin 1, and IGFBP1.
Shah et al. (2009) identified 236 proteins common to
endocervical columnar epithelial and vaginal mucosal human
cell lines by using stable isotope labeling by amino acids in cell
culture methodology. Fifteen proteins were selected as candidate
PTB biomarkers and the authors created a multiple reaction
monitoring assay to screen CVF samples (collected using Dacron
swabs). Three proteins, desmoplakin isoform 1, stratifin, and
thrombospondin 1 precursor were significantly elevated in five
asymptomatic womenwho had spontaneous PTB between 28 and
32 weeks of gestation compared to five controls who delivered at
term.
Lo et al. (2014) identified 15 CVF proteins differentially
expressed in asymptomatic women with recurrent PTB
compared to gestation-matched controls. CVF collected in
asymptomatic women (using Dacron swabs) were within 2–14
days before spontaneous PTB. Cysteine-rich secretory protein
3, heat shock protein beta 1, psoriasin and alpha enolase 1
demonstrated the largest difference in spectral counts between
controls and PTB. However, the authors could not confirm these
findings using enzyme-linked immunosorbent assays (ELISA) in
an independent cohort of 20 women.
The remainder of this review will summarize our team’s
breadth of work utilizing the CVF to identify biomarkers
associated with human labor. We describe the recruitment of
patients and the study cohorts, the methods used to identify and
quantify the differentially expressed proteins, the validation of
candidate biomarkers, the influence of vaginal microflora and
semen, and the challenges encountered in developing multiple
biomarker models to predict term and PTB.
Biomarkers Predictive of Human Labor
Patient Groups and Cervicovaginal Fluid
Collection
CVF samples were collected using a rayon double-tip swab and
processed using our published protocol (Di Quinzio et al., 2007).
At the time of sampling, a high vaginal swab was taken for
microbiology culture and assessment, and the participants were
asked whether they had (1) unprotected sexual intercourse in
the preceding 48 h; (2) recent vaginal bleeding; (3) an internal
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ultrasound or internal vaginal examination in the preceding 6 h;
and (4) antibiotic treatment. Obstetric, medical and demographic
data were also collected.
The CVF sample bank consisted of samples collected from
three groups of pregnant women:
1. Term labor: healthy, multiparous women with a singleton
pregnancy were recruited and sampled weekly starting
at 36 weeks of gestation until delivery. An in-labor
sample (i.e., spontaneous onset, intact membranes, cervical
dilatation >40mm) was collected, when possible.
2. At-risk of PTL: participants with at least one identified clinical
risk factor for preterm birth were recruited. The clinical
risk factors included multifetal pregnancy, history of PTL
or preterm PROM, heavy smoker, uterine anomaly (e.g.,
bicornuate uterus) and history of a cervical cone biopsy and/or
a shortened cervix (<25mm based on ultrasonographic
determination). CVF samples were collected serially from
participants with intact fetal membranes at four weekly
intervals, starting from 22 to 25 weeks of gestation until
36 weeks of gestation. Participants were stratified based on
birthing outcomes: spontaneous PTL, spontaneous preterm
PROM and spontaneous term labor.
3. Threatened PTL: women admitted with symptoms of preterm
labor between 22 and 36 weeks of gestation were recruited and
a single CVF sample was collected at the time of admission.
CVF was not collected if rupture of the fetal membranes
was confirmed owing to the likely contamination of the CVF
with amniotic fluid. Participants were not recruited if the
woman had experienced an internal vaginal examination or
transvaginal ultrasound in the preceding 6 h, was receiving
progesterone pessary treatment, had a cervical cerclage
in situ, experienced heavy antepartum hemorrhage, pre-
eclampsia, intra-uterine growth restriction, or hypertension.
Women presenting with suspected chorioamnionitis were
excluded as well as those subsequently diagnosed with bacterial
vaginosis.
Methods: Biomarker Discovery Using 2D-PAGE
and 2D-DIGE
2D electrophoretic methodologies (2D-PAGE and 2D-DIGE)
involve the combination of two orthogonal electrophoretic
separation processes on a gel at right angles to provide high
resolution separation of complex protein solutions. Proteins
are first separated in the first dimension based on their
isoelectric point followed by molecular weight separation in
the second dimension. While 2D-PAGE allows the comparison
between individual samples, 2D-DIGE is designed to compare
groups of pooled samples (Unlu et al., 1997). Following
electrophoresis, gels are stained with silver, dyes or fluorophores
for visualization and imaging. Each protein spot on a 2D
electrophoresis gel generally corresponds to a single protein or
an isoform of a protein. Using computer-assisted image analysis,
differentially expressed proteins and/or proteins of interest can be
subsequently excised from the gel and characterized using mass
spectrometry.
Detailed 2D-PAGE and 2D-DIGE protocols using CVF for
putative biomarker discovery have been published by our team
(Di Quinzio et al., 2007, 2008; Heng et al., 2010b; Liong et al.,
2013a,b).
All proteomic techniques have limitations. 2D electrophoresis
can be a laborious process and in turn may cause procedural
protein loss. A typical 2D electrophoresis protocol may result
in up to 80% of protein loss and therefore spot intensities
may not be reliable indicators of protein abundance in the
original sample (Zhou et al., 2005). The discovery of putative
biomarkers using 2D electrophoresis is restricted to “visible”
and sufficiently abundant protein spots. Low abundance proteins
may not be successfully identified or investigated and 2D
electrophoresis analysis may be affected by peptide fragmentation
resulting in two or more spots of the same protein. Often,
low abundance proteins can only be visualized after pre
fractionation and removal of high abundance proteins. Another
issue of 2D electrophoresis is the poor characterization of
water-insoluble proteins and transmembrane proteins (e.g.,
exosomes, membrane fragments and their associated proteins).
These proteins remain insoluble due to the use of non-
ionic chaotropic detergents (e.g., urea and thiourea) to re-
solubilize proteins after sample precipitation and low ionic
strength detergents (to generate high electric fields) during
IEF separation (Santoni et al., 2000). Despite the limitations
of 2D electrophoresis methods, they remain a useful tool
for biomarker discovery but these limitations highlight the
importance of performing appropriate independent validation
studies.
Methods: Biomarker Validation Using
Immunobased Techniques
Putative biomarkers associated with labor and identified by 2D
electrophoresis were validated using three techniques:
1. Western blot (protein immunoblot) is a semi-quantitative
method used to detect specific proteins in a sample (Burnette,
1981; Gorr and Vogel, 2015). In order to compare protein
expression between samples, the target protein is often
normalized against a “housekeeping” protein such as actin or
tubulin. However, as CVF lacks a housekeeping protein, we
normalized against the protein load of the sample.
2. ELISA can rapidly validate and quantify a target protein in
a given sample (Lequin, 2005). Although ELISA methods
are sensitive and specific in determining the concentration
of the target protein, a significant limitation of the ELISA
is that only one analyte can be quantified at a time.
This can be time consuming when measuring multiple
analytes.
3. Solution array multiple analyte profiling or multiplex assay
combines the technologies of dual laser flow cytometry,
microspheres, rapid digital signal processing and traditional
immunochemistry to allow the simultaneous quantitative
measurement of multiple analytes (up to 500 analytes) in a
96-well microplate format (Mandy et al., 2001; Elshal and
McCoy, 2006; Houser, 2012). This method is useful for rare
or volume-limited samples.
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Biomarker Discovery—Term Parturition
2D-PAGE and candidate-based multiple analyte profiling were
utilized to discover and characterize differential CVF protein
biomarkers associated with spontaneous onset of term labor.
In the first 2D-PAGE/MALDI-ToF study, proteins of 12-30 kDa
(using 8–16% Tris/HCl gels) were analyzed from paired CVF
samples collected from nine women at term. Samples were
collected 26–30 days before spontaneous labor onset, 1–2 days
before labor onset, and in labor prior to rupture of the fetal
membranes (Di Quinzio et al., 2008). Nine proteins were
differentially expressed 26–30 days before spontaneous term
labor onset compared to in-labor samples [annexin A3 (ANXA3),
serpin B4 (SERPINB4), copper, zinc superoxide dismutase
(SOD1), cystatin A (CSTA), epidermal fatty acid-binding protein
(FABP5), glutathione S-transferase pi 1 (GSTP1), interleukin-
1 receptor antagonist (IL1RN), peroxiredoxin-2 (PRDX2), and
thioredoxin-1 (TXN)]. ANXA3, CSTA, FABP5, SERPINB4, and
TXNwere also significantly altered 1–2 days prior to spontaneous
labor onset compared to the 26–30 day samples.
Protein spots in the upper section of the 8–16% gel (>37 kDa
region) were inadequately resolved for analysis. A subsequent
2D-PAGE study utilized 10% Tris/HCl gels and MALDI-ToF
to identify proteins between 25-45 kDa that were differentially
expressed in association with spontaneous term labor onset
(Heng et al., 2010b). Four serial samples from nine women were
collected at 14–17 days, 7–10 days, 0–3 days1 prior to term labor
as well as samples collected in-labor prior to rupture of the fetal
membranes. Albumin (ALB), ANXA3, serpin B1 (SERPINB1),
serpin B3 (SERPINB3) and collagen alpha 2 type IV (COL4A2)
were differentially expressed with spontaneous labor onset. It is
important to highlight that differential analyses were focused on
proteins common to all 2D electrophoresis gels within each study
(Di Quinzio et al., 2008; Heng et al., 2010b).
Biomarker Discovery—Preterm Parturition
2D-DIGE and 2D-PAGE analyses were performed on CVF
samples using 8–16% Tris/HCl gels from three distinct clinical
cohorts who subsequently experienced PTB: (1) asymptomatic
women assessed as clinically at-risk of PTB; (2) asymptomatic
women who subsequently experienced preterm PROM; and (3)
symptomatic women (i.e., presenting in PTL with the absence of
cervical dilatation). LC-ESI-MS/MS was used to identify proteins
that were differentially expressed in women who subsequently
delivered preterm compared to gestation-matched women who
delivered at term.
Asymptomatic Preterm Parturition
Proteomic analysis of the CVF obtained from asymptomatic
women 11–22 days prior to experiencing the onset of
spontaneous PTL and delivery (n = 5) revealed 15
proteins [ALB, apolipoprotein A1 (APOA1), CSTA, FABP5,
vitamin D binding protein (group-specific component, GC),
gamma-glutamylcyclotransferase (GGCT), GSTP1, IL1RN, S100
10 days signifies less than 24 h before spontaneous labor onset (in the absence of
symptoms and signs of labor).
calcium-binding protein A7 (S100A7), SERPINB3, serpin B4
(SERPINB4), serpin B6 (SERPINB6), SOD1, transaldolase
(TALDO1), and TXN] with significantly altered expression
compared to gestation-matched women who delivered at term
(n = 10) (Liong et al., 2013a).
Asymptomatic Preterm Pre-labor Rupture Of
Membranes
The current diagnosis of preterm PROM predominately relies on
clinical assessments including the visual detection of amniotic
fluid leaking from the cervical os and/or cervicovaginal discharge
presenting with an alkaline pH (nitrazine test) (Caughey et al.,
2008). The proteomic studies to date identified biomarkers that
serve to confirm suspected cases of preterm PROM (Vuadens
et al., 2003; Tambor et al., 2012; Chang et al., 2013) but no
proteomic studies that have identified biomarkers that may
predate preterm PROM. The early and accurate prediction of
preterm PROM could allow for timely intervention in order to
improve perinatal outcomes and reduce obstetric complications
such as chorioamnionitis, neonatal sepsis or cord prolapse
(Bengtson et al., 1989; Dale et al., 1989; Mercer et al., 1992)
Our group published the first prospective CVF proteomic
biomarker study in women who subsequently experienced
preterm PROM. Nine proteins (ANXA3, CSTA, FABP5,
GC, GGCT, IL1RN, SERPINB1, SERPINB3, and TXN) were
differentially expressed in asymptomatic women (n = 5) 6–
23 days before preterm PROM and delivered preterm compared
to gestation-matched controls who delivered at term (n = 10)
(Liong et al., 2013b).
Symptomatic Preterm Parturition
In the symptomatic cohort of preterm pregnant women, a
single CVF sample was obtained at the time of admission to
the Emergency Department. Following birthing outcomes, CVF
proteomic analysis was subsequently performed on samples
obtained from symptomatic women who presented with uterine
contractions in the absence of cervical change and experienced
spontaneous PTB (n = 4) and compared against gestation-
matched symptomatic women who subsequently delivered at
term (n = 8). 2D-DIGE and 2D-PAGE analyses identified
six proteins (ALB, CSTA, FABP5, GC, IL1RN, and TXN)
significantly differentially expressed in symptomatic women
40–54 days before spontaneous preterm birth (Liong et al., 2015).
Candidate Biomarker Validation—Term
Parturition
Based on the proteomic discovery findings described above,
a selected number of putative biomarkers were validated in
a large independent term cohort. In addition, a number
of biomarkers previously implicated in parturition were also
validated including those associated with inflammatory processes
[IL-1 alpha and beta (IL1A, IL1B)], oxidative stress defense
(total antioxidant capacity assay); andmatrix remodeling (matrix
metalloproteinases 1, 2, 3, 7, 8, and 9 (MMP1, MMP2, MMP3,
MMP7, MMP8, MMP9), tissue inhibitors of metalloproteinases
1 and 2 (TIMP1, TIMP2) and cysteine proteases [cathepsins
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B, H, and L (CTSB, CTSH, CTSL)]. Table 2 summarizes the
biomarkers that were successfully validated in large independent
cohorts using ELISA, multiple analyte profiling or enzyme
activity assay (Heng et al., 2008, 2010a, 2011, 2012, 2014b; Liong
et al., 2013c) and the predictive utilities of some of these putative
biomarkers have been published.
Candidate Biomarker Validation—Preterm
Parturition
Proteins differentially expressed with impending PTL in
asymptomatic and symptomatic women are summarized in
Table 3. For the basis of comparison, these biomarkers are
compared to those associated with term labor. This is a
generalized comparison as there is variation in the timing
of sample collection before labor between the cohorts. As
expected, not all of these novel biomarkers displayed a uniform
change between the different preterm pathologies. Indeed, some
biomarkers were either unique to women who experienced
preterm PROM or spontaneous PTL (with intact membranes).
These findings suggest that the mechanisms involved in preterm
PROM (with no infection) may be different from the processes
involved in spontaneous PTL with intact membranes. As the
content of the CVF is reflective of the changes occurring in the
surrounding tissues during cervical effacement and dilation, and
the rupture of fetal membranes, these biomarkers may provide
new insights into the timing and the biochemical changes prior
to the onset of labor.
Influence of Vaginal Microflora and Semen
An ideal diagnostic test should be robust to the high phenotypic
variation among patients caused by genetic, health, lifestyle
and environmental factors. Specifically, any biomarker study
or diagnostic test of the CVF must ensure that the biomarker
expression is resilient to the influences of latent vaginal
microflora, semen and vaginal bleeding. To determine the
influence of vaginal microflora on CVF proteins, upper vagina
microbiology culture and assessment was performed. Medical
laboratory pathology results were classified into five groups:
no significant pathogen identified, Group B Streptococcus
colonization, Candida spp. colonization, Ureaplasma spp.
Colonization, or mixed colonization (consisting of two or more
of these groups). Participants diagnosed with bacterial vaginosis
were excluded from the studies. To investigate if semen or vaginal
bleeding might influence CVF proteins, participants were asked
if they had had unprotected sexual intercourse in the preceding
48 h or vaginal bleeding within 24 h of CVF sampling.
From the microbiology results and patient responses,
validated biomarkers (ALB, CSTA, GC, IL1A, IL1B, IL1RN,
SOD1, TIMP1, TXN, and total antioxidant capacity) were not
influenced by common vaginal microflora or semen (Heng
et al., 2008, 2010a, 2011, 2012, 2014b; Liong et al., 2013a,c,
2015). However, the influence of unprotected sexual intercourse
(i.e., semen) on putative biomarkers may be limited by the
information volunteered by participants. The number of women
reporting vaginal bleeding was too low for analysis. Given that
many CVF proteins are also present in serum, it is possible that
any recent vaginal bleeding could influence the measurement
of these putative CVF biomarkers. In addition, the carriage
of certain gene polymorphisms (e.g., GC, IL1, and IL1RN) is
associated with differing levels of protein expression (Santtila
et al., 1998; Lauridsen et al., 2001; Pociot et al., 1992; Danis
et al., 1995; Genç et al., 2004) and it is conceivable that the
CVF expression of these proteins may be associated with specific
obstetric complications.
Multiple Biomarker Prediction of Human
Parturition and Its Challenges
The heterogeneity of spontaneous PTB and the various
clinical presentations (asymptomatic or symptomatic)
provide significant challenges for the identification of a
single biochemical marker to reliably predict all PTB (Menon
et al., 2011; Bhat et al., 2013). The concept of utilizing multiple
biochemical markers to improve labor prediction has been
reported by our team (Heng et al., 2010a, 2014b; Liong et al.,
2015) and others (Rizzo et al., 1998; Goldenberg et al., 2001;
Kishida et al., 2003; Grenache et al., 2004; Taylor et al., 2013).
Other variations of using a diagnostic panel to predict PTB
include incorporating peripheral blood results, gene expression
profiles (Heng et al., 2014a) as well as combining demographic,
physical and behavioral parameters (e.g., cervical length or illicit
drug use) (Hincz et al., 2002; Schmitz et al., 2006; Dutta and
Norman, 2010; Bolt et al., 2011; Dekker et al., 2012; Fox et al.,
2012; DeFranco et al., 2013).
TABLE 2 | Validated putative biomarkers associated with term labor.
Function Significantly increased Significantly decreased No significant changes References
Inflammation/anti-inflammation IL1A, IL1B IL1RN Heng et al., 2008,
2014b
Oxidative stress defense SOD1, TXN, total antioxidant capacity* Heng et al., 2010a
Cysteine proteases/inhibitors CSTA CTSB*, CTSH*, CTSL* Heng et al., 2011
Metallo proteases/inhibitors MMP7, TIMP1, TIMP2 MMP1, MMP2, MMP3, MMP8, MMP9 Heng et al., 2012
Carrier/transport GC Liong et al., 2013c
CVF samples were taken from 36 weeks of gestation and all women labored spontaneously at term. *Activity assay.
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TABLE 3 | Putative biomarkers associated with preterm labor compared to term labor.
Term Labor+ Asymptomatic Preterm Labor (PTL)+ Asymptomatic Preterm Pre-labor
Rupture of Membranes (PROM)*
Symptomatic Preterm
Labor (PTL)+
Samples beyond 36 weeks of
gestation including in-labor
before rupture of membranes
Two to twenty two days before
spontaneous PTL (For GC, samples
collected up to 120 days before
spontaneous PTL)
Two to twenty days before
spontaneous preterm PROM
Zero to fifty four days before
spontaneous PTL
IL1RN ↓ ↓ ↓ ↔
(n = 240; 292 term) (n = 15 preterm, n = 83 term) (n = 5 preterm, n = 10 term) (n = 16 preterm, n = 101
term)
CSTA ↓ ↔ ↓ ↓
(n = 247 term) (n = 21 preterm, n = 59 term) (n = 5 preterm, n = 10 term) (n = 4 preterm, n = 8 term,
based on 2D-PAGE only)
TXN ↓ ↓ ↔ ↔
(n = 163 term) (n = 13 preterm, n = 55 term) (n = 5 preterm, n = 10 term) (n = 14 preterm, n = 86
term)
SOD1 ↓ ↔ ↔ ↔
(n = 170 term) (n = 24 preterm, n = 89 term) (n = 5 preterm, n = 10 term, based
on 2D-PAGE only)
(n = 4 preterm, n = 8 term,
based 2D-PAGE only)
ALB ↑ ↔ ↑ ↑
(n = 36 term based on 2D-PAGE
only)
(n = 14 preterm, n = 59 term) (n = 5 preterm, n = 10 term based on
2D-PAGE only)
(n = 19 preterm, n = 98
term)
GC ↑ ↑ ↔ ↑
(n = 352 term) (n = 89 preterm, n = 372 term) (n = 5 preterm, n = 10 term) (n = 16 preterm, n = 97
term)
ANXA3 ↓ ↑
(n = 36 term based on 2D-PAGE
only)
(n = 5 preterm, n = 10 term)
References Heng et al., 2008, 2010a,b,
2011, 2014b; Liong et al., 2013c
Liong et al., 2013a,c Liong et al., 2013b Liong et al., 2015
+Validated by ELISA unless stated otherwise. *Validated by Western Blot unless stated otherwise.
Along with obtaining quality samples, performing rigorous
clinical phenotyping and/or sub-classification of PTB,
establishing reproducible analytical assays and analysing the data
prudently, another significant challenge to establishing a clinical
screening or diagnostic test for PTB involves the construction
of a well-fitted predictive model. There is no consensus on a
standard statistical approach to construct a multiple biomarker
predictive model of labor. Here, we propose some important
factors that should be considered when constructing a model. It
should be emphasized that statistical significance does not always
translate into clinical utility. Biomarkers that display a significant
association with labor but may display only a small fold-change
between groups and/or a large variance within groups are not
likely to be clinically useful for discriminating outcomes.
Developing a Predictive Model for Each Clinical
Subgroup of PTB
A model optimized to predict idiopathic spontaneous PTB may
have compromised predictive capacities for PTB with known
infection, PTB with multifetal gestation or preterm PROM. It
may therefore be necessary to assess and consider numerous
clinical parameters as confounders. Alternatively, an ideal test
that could predict any possible outcome is likely to require several
biomarkers that may be “unique” to each clinical subgroup.
Determining a Clinically Useful Prediction
“Window”
Different clinical presentations (e.g., at-risk asymptomatic or
symptomatic women) would benefit from different sampling-to-
outcome time frames or “windows.” This window will influence
the type of intervention and obstetric management for each
woman. For example, in women with symptoms of PTL where
delivery may be imminent, a narrow prediction window of 24–
48 h would be important for a clinician to decide whether or not
to administer corticosteroids for fetal lung maturation and/or
to transport the woman to a tertiary hospital with advanced
neonatal facilities (Goldenberg, 2002; Heng et al., 2014a, 2015).
Alternatively, a wide prediction window, perhaps 14–28 days
would be more appropriate for asymptomatic women that will
allow clinicians to place a patient under surveillance and provide
therapeutic measures such as progesterone to prevent PTB.
Selecting the Most Appropriate Biomarkers
A reliable predictive model should be highly sensitive and
specific while incorporating the fewest number of biomarkers
being measured. Selecting biomarkers involved in different
biochemical pathways (e.g., inflammation, ECM remodeling,
oxidative stress) may value-add to a predictive test. Genetic
polymorphisms associated with PTB could also be included as
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part of a predictive test. Similarly, one of the major advantages
of proteomic methodologies is the ability to identify and
compare the expression profiles of different protein isoforms.
For example, the different isoforms of CSTA, FABP5, SERPINB1,
and SERPINB3 displayed differing expression profiles with labor
onset and the relative abundance of each isoform also varied
enormously. Whilst the selection of a particular protein isoform
or a genetic polymorphism may enhance a predictive test, they
may be less suitable for the development of an inexpensive and
rapid bedside test kit.
Using Single or Multiple Sampling Time Points
Given the large variation in biomarker concentrations between
patients, the use of serial samples from the same women
to determine the “change” in biomarker concentration (i.e.,
comparing subsequent analytemeasurements against a “baseline”
reference point) rather than the absolute concentration value
may be more informative. Determining when this baseline
measurement should be performed could be based upon fetal
viability (23 weeks of gestation).
Deciding the Optimal Diagnostic Concentration
Threshold for Each Biomarker
Firstly, a decision should be made whether to correct the
biomarker concentration to the total protein content of the
CVF. This may provide a more meaningful measurement of the
biomarker but would not be practical for a rapid bedside test
utilizing a “dip-stick” approach similar to the fFN or phIGFBP1
tests. Furthermore, the desired sensitivity or specificity ultimately
determines the concentration threshold for a positive or negative
test. For example, an ideal PTB test needs to be highly sensitive
where a “positive” outcome (imminent delivery) would require
medical intervention to prevent labor. On the other hand, a
highly specific test could be useful for predicting post-term labor
as a “negative” outcome (where delivery is unlikely to occur
within a defined period) would require medical intervention(s)
such as induction or elective Cesarean delivery.
Consideration of Demographic, Physical, and
Behavioral Confounders
A reliable predictive test should be robust to the numerous
confounding variables at play but could also be strengthened
by incorporating various demographic (e.g., maternal age,
ethnicity), biochemical (e.g., peripheral blood data), physical
(e.g., cervical length, uterine anomaly), or behavioral (e.g., poor
nutrition, illicit drug use) confounders into the predictive model
(Dekker et al., 2012; Heng et al., 2014a).
Taking some of the above points into consideration, we have
previously published the predictive utility of selected biomarkers
using binary logistic regression (Heng et al., 2010a, 2014b; Liong
et al., 2013a, 2015). We have demonstrated a superior predictive
potential for labor when a combination of biochemical markers
is compared with each individual biomarker. Three cytokines,
IL1A, IL1B, and IL1RN were evaluated to predict spontaneous
term labor within 3 days of sampling. As individual biomarkers,
term delivery could be predicted with 52.8% sensitivity and
77.4% specificity (PPV 33.3%) using IL1A, 52.8% sensitivity
and 66.1% specificity (PPV 25.0%) using IL1B and 52.8%
TABLE 4 | The efficiency of putative biomarkers compared with fetal fibronectin to predict preterm labor.
Cervicovaginal fluid Time to Sensitivity Specificity Positive Negative Positive Negative References
biomarker(s) labor (days) Likelihood Likelihood predictive predictive
Ratio (LR+) Ratio (LR−) value value
SPONTANEOUS PRETERM LABOR (ASYMPTOMATIC)
fFN (meta-analysis) 7 22 (3–60) 97 (96–97) 7.3 0.80 NR NR Leitich et al., 1999b
fFN (meta-analysis) 14 43 (0–95) 95 (92–99) 8.6 0.60 NR NR Leitich et al., 1999b
fFN (meta-analysis) 28 26 (3–50) 97 (96–98) 8.7 0.76 NR NR Leitich et al., 1999b
GC 7 57.7 96.6 17.0 0.44 78.8 91.2 Liong et al., 2013c
GC 14 71.2 87.9 5.9 0.33 69.9 88.5 Liong et al., 2013c
IL1RN 28 57.1 97.8 26.0 0.44 72.7 95.7 Liong et al., 2013a
TRX 28 64.3 97.8 29.2 0.37 75.0 96.4 Liong et al., 2013a
IL1RN + TRX 28 64.3 97.8 29.2 0.37 75.0 96.4 Liong et al., 2013a
THREATENED PRETERM LABOR (SYMPTOMATIC)
fFN (meta-analysis) 7 76 (69–82) 82 (79–84) 4.2 (3.5–5.0) 0.29 (0.22–0.38) NR NR Sanchez-Ramos
et al., 2009
fFN (meta-analysis) 7 75 (69–80) 79 (76–83) 3.6 (3.1–4.3) 0.31 (0.25–0.39) NR NR Boots et al., 2014
fFN 7 66.7 87.9 5.5 0.38 36.4 96.2 Liong et al., 2015
IL1RN 7 88.9 50.9 1.8 0.22 13.1 98.2 Liong et al., 2015
TRX 7 55.6 79.1 2.7 0.56 20.8 94.7 Liong et al., 2015
ALB 7 83.3 73.3 3.1 0.23 26.3 97.5 Liong et al., 2015
GC 7 77.8 98.1 40.9 0.23 77.8 98.1 Liong et al., 2015
ALB + GC 7 77.8 100 >100 0.22 100 98.0 Liong et al., 2015
NR, not reported; Range shown represents 95% confidence interval.
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sensitivity and 76.2% specificity (PPV 32.2%) using IL1RN. A
combined cytokine model yielded 86.1% sensitivity and 91.7%
specificity (PPV 68.9%) to predict labor. In this case, multiple
sampling from the same woman was able to provide improved
predictive efficacy even without the inclusion of demographic
confounding variables (Heng et al., 2014b). In another example,
ALB and GC were evaluated to predict PTL within 7 days
in symptomatic women. As individual biomarkers, ALB could
predict spontaneous preterm delivery with 83.3% sensitivity and
73.3% specificity (PPV 26.3%), whereas GC provided a sensitivity
of 77.8% and specificity of 98.1% (PPV 77.8%). Prediction of
preterm delivery within 7 days using the combined model of
ALB and GC, yielded a sensitivity of 77.8%, a specificity of 100%
and with 100% PPV and 98.0% NPV (Liong et al., 2015). A
clinical diagnostic trial is required to test these models on a
larger population to confirm these findings and further refine
the predictive values. For the basis of comparison to fFN, the
predictive utility of our candidate biomarkers in asymptomatic
and symptomatic cohorts is summarized in Table 4.
Concluding Remarks
The prediction and prevention of PTB remains one of the crucial
challenges facing modern obstetrics. The reliable identification
of women at-risk of PTB will allow the tailoring of medical
intervention and therapeutic treatments aimed at improving
maternal and fetal outcomes. It is likely that the multifaceted
etiology of PTB would require a multiple biomarker test.
The CVF is an excellent biological fluid for the discovery of
biomarkers associated with labor due to its proximity to the
gestational tissues that undergo dramatic changes with advancing
gestation. Proteomic approaches have enabled the discovery
of novel biomarkers in the CVF involved in the physiology
of labor and/or pathophysiology of PTB. These proteins have
functional roles in inflammation, ECM remodeling and oxidative
stress and are involved in cervical ripening and/or membrane
rupture. The next phase of our work will be to validate our
data with independent cohorts and integrate biochemical data
with demographic, physical and behavioral information using
bioinformatics approaches to develop reliable predictive models
for PTB.
Acknowledgments
Research work was supported by a National Health and Medical
Research Council of Australia Development Grant (NHMRC
#454451, HMG, MKWD, GER); Australian & New Zealand
Journal of Obstetrics and Gynaecology Research Scholarship
(MKWD); NHMRC Biomedical (Dora Lush) Postgraduate
Research Scholarship (#454880, YJH); Australian Postgraduate
Award (Australian Government Department of Industry, SL); the
Medical Research Foundation for Women and Babies; and the
Shepherd Foundation. The authors gratefully acknowledge the
assistance of research midwives (particularly Gabrielle Pell and
Valery Bryant), clinical staff and patients of the Mercy Hospital
for Women.
References
Adachi, S., and Oku, M. (1995). The regulation of oxytocin receptor expression in
human myometrial monolayer culture. J. Smooth Muscle Res. 31, 175–187. doi:
10.1540/jsmr.31.175
Adams, M. M., Elam-Evans, L. D., Wilson, H. G., and Gilbertz, D. A. (2000).
Rates of and factors associated with recurrence of preterm delivery. JAMA 283,
1591–1596. doi: 10.1001/jama.283.12.1591
Agrez, M., Gu, X., and Giles, W. (1999). Matrix metalloproteinase 9 activity in
urine of patients at risk for premature delivery. Am. J. Obstet. Gynecol. 181,
387–388. doi: 10.1016/S0002-9378(99)70566-1
AIHW, Li, Z., Zeki, R., Hilder, L., and Sullivan, E. (2012). Australia’s mothers and
babies 2010. Perinatal Statistics Series no 27 Cat no PER 57. Canberra, ACT:
AIHW.
Alaiya, A. A., Franzén, B., Moberger, B., Silfverswärd, C., Linder, S., and Auer,
G. (1999). Two-dimensional gel analysis of protein expression in ovarian
tumors shows a low degree of intratumoral heterogeneity. Electrophoresis 20,
1039–1046.
Ananth, C., and Vintzileos, A. (2006). Epidemiology of preterm birth and
its clinical subtypes. J. Matern. Fetal Neonatal Med. 19, 773–782. doi:
10.1080/14767050600965882
Andrews, W. W., Tsao, J., Goldenberg, R. L., Hauth, J. C., Mercer, B., Iams,
J., et al. (1999). The preterm prediction study: failure of midtrimester
cervical sialidase level elevation to predict subsequent spontaneous preterm
birth. Am. J. Obstet. Gynecol. 180, 1151–1154. doi: 10.1016/S0002-9378(99)
70609-5
Bae, S. M., Lee, C. H., Cho, Y. L., Nam, K. H., Kim, Y. W., Kim, C. K.,
et al. (2005). Two-dimensional gel analysis of protein expression profile
in squamous cell cervical cancer patients. Gynecol. Oncol. 99, 26–35. doi:
10.1016/j.ygyno.2005.05.041
Barden, T. P., Peter, J. B., and Merkatz, I. R. (1980). Ritodrine hydrochloride: a
betamimetic agent for use in preterm labor. I. pharmacology, clinical history,
administration, side effects, and safety. Obstet. Gynecol. 56, 1–6.
Bengtson, J. M., VanMarter, L. J., Barss, V. A., Greene, M. F., Tuomala, R. E.,
and Epstein, M. F. (1989). Pregnancy outcome after premature rupture of the
membranes at or before 26 weeks’ gestation. Obstet. Gynecol. 73, 921–927.
Berghella, V., Baxter, J. K., and Hendrix, N. W. (2013). Cervical assessment
by ultrasound for preventing preterm delivery. Cochrane Database Syst. Rev.
1:CD007235. doi: 10.1002/14651858.CD007235
Bhat, G., Williams, S. M., Saade, G. R., and Menon, R. (2013). Biomarker
interactions are better predictors of spontaneous preterm birth. Reprod. Sci. 21,
340–350. doi: 10.1177/1933719113497285
Bolt, L. A., Chandiramani, M., De Greeff, A., Seed, P. T., Kurtzman, J., and
Shennan, A. H. (2011). The value of combined cervical length measurement
and fetal fibronectin testing to predict spontaneous preterm birth in
asymptomatic high-risk women. J. Matern. Fetal Neonatal Med. 24, 928–932.
doi: 10.3109/14767058.2010.535872
Boots, A. B., Sanchez-Ramos, L., Bowers, D. M., Kaunitz, A. M., Zamora, J.,
and Schlattmann, P. (2014). The short-term prediction of preterm birth: a
systematic review and diagnostic metaanalysis. Am. J. Obstet. Gynecol. 210,
54.e1–54.e10. doi: 10.1016/j.ajog.2013.09.004
Buhimschi, I. A., Christner, R., and Buhimschi, C. S. (2005). Proteomic biomarker
analysis of amniotic fluid for identification of intra-amniotic inflammation.
BJOG 112, 173–181. doi: 10.1111/j.1471-0528.2004.00340.x
Bujold, E., Romero, R., Kusanovic, J. P., Erez, O., Gotsch, F., Chaiworapongsa, T.,
et al. (2008). Proteomic profiling of amniotic fluid in preterm labor using two-
dimensional liquid separation andmass spectrometry. J. Matern. Fetal Neonatal
Med. 21, 697–713. doi: 10.1080/14767050802053289
Burnette, W. N. (1981). “Western blotting”: electrophoretic transfer of proteins
from sodium dodecyl sulfate–polyacrylamide gels to unmodified nitrocellulose
Frontiers in Physiology | www.frontiersin.org 12 May 2015 | Volume 6 | Article 151
Heng et al. Biomarkers of term and preterm birth
and radiographic detection with antibody and radioiodinated protein A. Anal.
Biochem. 112, 195–203. doi: 10.1016/0003-2697(81)90281-5
Burton, G. J., and Jauniaux, E. (2010). Oxidative stress. Best Pract. Res. Clin. Obstet.
Gynaecol. 25, 287–299. doi: 10.1016/j.bpobgyn.2010.10.016
Butt, R. H., Lee, M. W., Prishahid, S. A., Backlund, P. S., Wood, S., and Coorssen,
J. R. (2006). An initial proteomic analysis of human preterm labor: placental
membranes. J. Proteome Res. 5, 3161–3172. doi: 10.1021/pr060282n
Carlson, S. E., Colombo, J., Gajewski, B. J., Gustafson, K. M., Mundy, D., Yeast,
J., et al. (2013). DHA supplementation and pregnancy outcomes. Am. J. Clin.
Nutr. 97, 808–815. doi: 10.3945/ajcn.112.050021
Caughey, A. B., Robinson, J. N., and Norwitz, E. R. (2008). Contemporary
diagnosis and management of preterm premature rupture of membranes. Rev.
Obstet. Gynecol. 1, 11–22.
Chai, M., Barker, G., Menon, R., and Lappas, M. (2012). Increased oxidative
stress in human fetal membranes overlying the cervix from term
non-labouring and post labour deliveries. Placenta 33, 604–610. doi:
10.1016/j.placenta.2012.04.014
Challis, J. R. G., Lye, S. J., Gibb, W., Whittle, W., Patel, F., and Alfaidy, N.
(2003). Understanding preterm labor. Ann. N.Y. Acad. Sci. 943, 225–234. doi:
10.1111/j.1749-6632.2001.tb03804.x
Challis, J. R. G., Matthews, S. G., Gibb, W., and Lye, S. J. (2000). Endorine and
paracrine regulation of birth at term and preterm. Endocr. Rev. 21, 514–550.
doi: 10.1210/edrv.21.5.0407
Chang, A., Zhang, Z., Zhang, L., Gao, Y., Zhang, L., Jia, L., et al. (2013). Proteomic
analysis of preterm premature rupture of membranes in placental tissue. Arch.
Gynecol. Obstet. 288, 775–784. doi: 10.1007/s00404-013-2837-5
Colantonio, D. A., and Chan, D. W. (2005). The clinical application of proteomics.
Clin. Chim. Acta 357, 151–158. doi: 10.1016/j.cccn.2005.03.020
Coleman, M. A., Keelan, J. A., McCowan, L. M., Townend, K. M., and
Mitchell, M. D. (2001). Predicting preterm delivery: comparison of
cervicovaginal interleukin (IL)-1beta, IL-6 and IL-8 with fetal fibronectin
and cervical dilatation. Eur. J. Obstet. Gynecol. Reprod. Biol. 95, 154–158. doi:
10.1016/S0301-2115(00)00450-4
Conde-Agudelo, A., Papageorghiou, A. T., Kennedy, S. H., and Villar, J. (2011).
Novel biomarkers for the prediction of the spontaneous preterm birth
phenotype: a systematic review and meta-analysis. BJOG 118, 1042–1054. doi:
10.1111/j.1471-0528.2011.02923.x
Coon, J. J., Zürbig, P., Dakna, M., Dominiczak, A. F., Decramer, S., Fliser, D.,
et al. (2008). CE-MS analysis of the human urinary proteome for biomarker
discovery and disease diagnostics. Proteomics Clin. Appl. 2, 964–973. doi:
10.1002/prca.200800024
Costeloe, K. L., Hennessy, E. M., Haider, S., Stacey, F., Marlow, N., and Draper,
E. S. (2012). Short term outcomes after extreme preterm birth in England:
comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ
345:e7976. doi: 10.1136/bmj.e7976
Crane, J. M., and Hutchens, D. (2008). Use of transvaginal ultrasonography to
predict preterm birth in women with a history of preterm birth. Ultrasound
Obstet. Gynecol. 32, 640–645. doi: 10.1002/uog.6143
Dale, P. O., Tanbo, T., Bendvold, E., and Moe, N. (1989). Duration of the latency
period in preterm premature rupture of the membranes. Maternal and neonatal
consequences of expectant management. Eur. J. Obstet. Gynecol. Reprod. Biol.
30, 257–262. doi: 10.1016/0028-2243(89)90010-5
Danis, V. A., Millington, M., Hyland, V. J., and Grennan, D. (1995). Cytokine
production by normal human monocytes: inter-subject variation and
relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.
Clin. Exp. Immunol. 99, 303–310. doi: 10.1111/j.1365-2249.1995.
tb05549.x
Darne, J., McGarrigle, H. H., and Lachelin, G. C. (1987). Increased saliva oestriol
to progesterone ratio before preterm delivery: a possible predictor for preterm
labor? Br. Med. J. (Clin. Res. Ed). 294, 270–272.
Dasari, S., Pereira, L., Reddy, A. P., Michaels, J. E., Lu, X., Jacob, T., et al. (2007).
Comprehensive proteomic analysis of human cervical-vaginal fluid. J. Proteome
Res. 6, 1258–1268. doi: 10.1021/pr0605419
DeFranco, E. A., Lewis, D. F., and Odibo, A. O. (2013). Improving the
screening accuracy for preterm labor: is the combination of fetal fibronectin
and cervical length in symptomatic patients a useful predictor of preterm
birth? A systematic review. Am. J. Obstet. Gynecol. 208, 233.e1–233.e6. doi:
10.1016/j.ajog.2012.12.015
Dekker, G. A., Lee, S. Y., North, R. A., McCowan, L. M., Simpson, N.
A., and Roberts, C. T. (2012). Risk factors for preterm birth in an
international prospective cohort of nulliparous women. PLoS ONE 7:e39154.
doi: 10.1371/journal.pone.0039154
Di Quinzio, M. K., Georgiou, H. M., Holdsworth-Carson, S. J., Ayhan, M., Heng,
Y. J., Walker, S. P., et al. (2008). Proteomic analysis of human cervico-vaginal
fluid displays differential protein expression in association with labor onset at
term. J. Proteome Res. 7, 1916–1921. doi: 10.1021/pr7006413
Di Quinzio, M. K., Oliva, K., Holdsworth, S. J., Ayhan,M.,Walker, S. P., Rice, G. E.,
et al. (2007). Proteomic analysis and characterisation of human cervico-vaginal
fluid proteins. Aust. N.Z. J. Obstet. Gynaecol. 47, 9–15. doi: 10.1111/j.1479-
828X.2006.00671.x
Dutta, D., and Norman, J. E. (2010). The efficacy of fetal fibronectin testing in
minimising hospital admissions, length of hospital stay and cost savings in
women presenting with symptoms of pre-term labour. J. Obstet. Gynaecol. 30,
768–773. doi: 10.3109/01443615.2010.518259
Ekerhovd, E., Weijdegård, B., Brannström, M., Mattsby-Baltzer, I., and Norström,
A. (2002). Nitric oxide induced cervical ripening in the human: involvement of
cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin
E(2). Am. J. Obstet. Gynecol. 186, 745–750. doi: 10.1067/mob.2002.121327
El Khwad, M., Pandey, V., Stetzer, B., Mercer, B. M., Kumar, D., Moore, R. M., et al.
(2006). Fetal membranes from term vaginal deliveries have a zone of weakness
exhibiting characteristics of apoptosis and remodeling. J. Soc. Gynecol. Investig.
13, 191–195. doi: 10.1016/j.jsgi.2005.12.010
Elshal, M. F., and McCoy, J. P. (2006). Multiplex bead array assays: performance
evaluation and comparison of sensitivity to ELISA. Methods 38, 317–323. doi:
10.1016/j.ymeth.2005.11.010
Esplin, M. S., Merrell, K., Goldenberg, R., Lai, Y., Iams, J. D., Mercer, B., et al.
(2011). Proteomic identification of serum peptides predicting subsequent
spontaneous preterm birth. Am. J. Obstet. Gynecol. 204, 391.e1–391.e8. doi:
10.1016/j.ajog.2010.09.021
Farina, M. G., Billi, S., Leguizamon, G., Weissmann, C., Guadagnoli, T., Ribeiro,
M. L., et al. (2007). Secretory and cytosolic phospholipase A2 activities and
expression are regulated by oxytocin and estradiol during labor. Reproduction
134, 355–364. doi: 10.1530/REP-07-0078
Field, D. J., Dorling, J. S., Manktelow, B. N., and Draper, E. S. (2008). Survival of
extremely premature babies in a geographically defined population: prospective
cohort study of 1994-9 compared with 2000-5. BMJ 336, 1221–1223. doi:
10.1136/bmj.39555.670718.BE
Fortunato, S. J., and Menon, R. (2001). Distinct molecular events suggest different
pathways for preterm labor and premature rupture of membranes. Am. J.
Obstet. Gynecol. 184, 1399–1405. doi: 10.1067/mob.2001.115122
Fotopoulou, C., Kyeyamwa, S., Linder, M., Thieme, D., Hartenstein, S., Klein, O.,
et al. (2012). Proteomic analysis of midtrimester amniotic fluid to identify novel
biomarkers for preterm delivery. J. Matern. Fetal Neonatal Med. 25, 2488–2493.
doi: 10.3109/14767058.2012.712565
Fox, N. S., Rebarber, A., Roman, A. S., Klauser, C. K., Peress, D., and Saltzman,
D. H. (2012). Combined fetal fibronectin and cervical length and spontaneous
preterm birth in asymptomatic triplet pregnancies. J. Matern. Fetal Neonatal
Med. 25, 2308–2311. doi: 10.3109/14767058.2012.691579
Garshasbi, A., Ghazanfari, T., and Faghih Zadeh, S. (2004). Beta-human chorionic
gonadotrophin in cervicovaginal secretions and preterm delivery. Int. J.
Gynaecol. Obstet. 86, 358–364. doi: 10.1016/j.ijgo.2004.05.006
Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J.,
Davidson, A. H., et al. (1994). Processing of tumour necrosis factor-alpha
precursor by metalloproteinases. Nature 370, 555–557. doi: 10.1038/370555a0
Genç, M. R., Gerber, S., Nesin, M., and Witkin, S. S. (2002). Polymorphism in the
interleukin-1 gene complex and spontaneous preterm delivery. Am. J. Obstet.
Gynecol. 187, 157–163. doi: 10.1067/mob.2002.122407
Genç, M. R., Onderdonk, A. B., Vardhana, S., Delaney, M. L., Norwitz, E. R.,
Tuomala, R. E., et al. (2004). Polymorphism in intron 2 of the interleukin-1
receptor antagonist gene, local midtrimester cytokine response to vaginal flora,
and subsequent preterm birth. Am. J. Obstet. Gynecol. 191, 1324–1330. doi:
10.1016/j.ajog.2004.05.074
Gilbert, W. M. (2006). The cost of preterm birth: the low cost versus high value of
tocolysis. BJOG 113, 4–9. doi: 10.1111/j.1471-0528.2006.01117.x
Goffinet, F. (2005). Primary predictors of preterm labour. BJOG 112, 38–47. doi:
10.1111/j.1471-0528.2005.00583.x
Frontiers in Physiology | www.frontiersin.org 13 May 2015 | Volume 6 | Article 151
Heng et al. Biomarkers of term and preterm birth
Goldenberg, R. L. (2002). The management of preterm labor. Obstet. Gynecol.
100(Pt 1), 1020–1037. doi: 10.1016/S0029-7844(02)02212-3
Goldenberg, R. L., Iams, J. D., Mercer, B. M., Meis, P. J., Moawad, A., Das, A.,
et al. (2001). The preterm prediction study: toward a multiple-marker test
for spontaneous preterm birth. Am. J. Obstet. Gynecol. 185, 643–651. doi:
10.1067/mob.2001.116752
Goldenberg, R. L.,Mercer, B.M.,Meis, P. J., Copper, R. L., Das, A., andMcNellis, D.
(1996). The preterm prediction study: fetal fibronectin testing and spontaneous
preterm birth. Obstet. Gynecol. 87, 643–648. doi: 10.1016/0029-7844(96)
00035-X
Gomez, R., Romero, R., Medina, L., Nien, J. K., Chaiworapongsa, T., Carstens, M.,
et al. (2005). Cervicovaginal fibronectin improves the prediction of preterm
delivery based on sonographic cervical length in patients with preterm uterine
contractions and intact membranes. Am. J. Obstet. Gynecol. 192, 350–359. doi:
10.1016/j.ajog.2004.09.034
Gorr, T. A., and Vogel, J. (2015). Western blotting re-visited: critical perusal
of under-appreciated technical issues. Proteomics Clin. Appl. 9, 396–405. doi:
10.1002/prca.201400118
Gravett, M., Novy, M., Rosenfeld, R., Reddy, A., Jacob, T., Turner, M., et al. (2004).
Diagnosis of intra-amniotic infection by proteomic profiling and identification
of novel biomarkers. JAMA 292, 462–469. doi: 10.1001/jama.292.4.462
Greenough, A., Limb, E., Marston, L., Marlow, N., Calvert, S., and Peacock,
J. (2005). Risk factors for respiratory morbidity in infancy after very
premature birth. Arch. Dis. Child. Fetal Neonatal Ed. 90, F320–F323. doi:
10.1136/adc.2004.062018
Grenache, D. G., Hankins, K., Parvin, C. A., and Gronowski, A. M. (2004).
Cervicovaginal interleukin-6, tumor necrosis factor-alpha, and interleukin-
2 receptor as markers of preterm delivery. Clin. Chem. 50, 1839–1842. doi:
10.1373/clinchem.2004.034280
Guaschino, S., De Seta, F., Piccoli, M., Maso, G., and Alberico, S. (2006). Aetiology
of preterm labour: bacteria vaginosis. BJOG 113, 46–51. doi: 10.1111/j.1471-
0528.2006.01122.x
Haddad, R., Tromp, G., Kuivaniemi, H., Chaiworapongsa, T., Kim, Y. M.,
Mazor, M., et al. (2006). Human spontaneous labor without histologic
chorioamnionitis is characterized by an acute inflammation gene expression
signature. Am. J. Obstet. Gynecol. 195, 394. doi: 10.1016/j.ajog.2005.
08.057
Hall, M. H., Danielian, P., and Lamont, R. F. (1997). “The importance of preterm
birth,” in Preterm Labor, eds M. G. Elder, R. Romero, and R. F. Lamont (New
York, NY: Churchill Livingstone Inc.), 1–28.
Hellman, K., Alaiya, A. A., Schedvins, K., Steinberg,W., Hellström, A. C., andAuer,
G. (2004). Protein expression patterns in primary carcinoma of the vagina. Br.
J. Cancer 91, 319–326. doi: 10.1038/sj.bjc.6601944
Heng, Y. J., Di Quinzio, M. K., Liong, S., Permezel, M., Rice, G. E., and Georgiou,
H. M. (2012). Temporal investigation of matrix metalloproteinases and their
inhibitors in human cervicovaginal fluid in late pregnancy and labor. Reprod.
Sci. 19, 55–63. doi: 10.1177/1933719111413299
Heng, Y. J., Di Quinzio, M. K., Permezel, M., Ayhan, M., Rice, G. E.,
and Georgiou, H. M. (2010b). Temporal proteomic analysis of human
cervicovaginal fluid with impending term labor. J. Proteome Res. 9, 1344–1350.
doi: 10.1021/pr900892f
Heng, Y. J., Di Quinzio, M. K., Permezel, M., Rice, G. E., and Georgiou,
H. M. (2008). Interleukin-1 receptor antagonist in human cervicovaginal
fluid in term pregnancy and labor. Am. J. Obstet. Gynecol. 199, 656. doi:
10.1016/j.ajog.2008.06.011
Heng, Y. J., Di Quinzio, M. K., Permezel, M., Rice, G. E., and Georgiou, H. M.
(2010a). Temporal expression of antioxidants in human cervicovaginal fluid
associated with spontaneous labor. Antioxid. Redox Signal. 13, 951–957. doi:
10.1089/ars.2010.3122
Heng, Y. J., Di Quinzio, M. K., Permezel, M., Rice, G. E., and Georgiou, H.
M. (2011). Cystatin A protease inhibitor and cysteine proteases in human
cervicovaginal fluid in term pregnancy and labor. Am. J. Obstet. Gynecol. 204,
254.e1–254.e7. doi: 10.1016/j.ajog.2010.10.912
Heng, Y. J., Liong, S., Permezel, M., Rice, G. E., Di Quinzio, M. K., and Georgiou,
H.M. (2014b). The interplay of the interleukin 1 system in pregnancy and labor.
Reprod. Sci. 21, 122–130. doi: 10.1177/1933719113492204
Heng, Y. J., Pennell, C. E., Chua, H. N., Perkins, J. E., and Lye, S. J. (2014a).
Whole blood gene expression profile associated with spontaneous preterm
birth in women with threatened preterm labor. PLoS ONE 9:e96901. doi:
10.1371/journal.pone.0096901
Heng, Y. J., Taylor, L., Larsen, B. G., Chua, H. N., Pung, S. M., Lee, M. W.,
et al. (2015). Albumin decrease is associated with spontaneous preterm delivery
within 48 h in women with threatened preterm labor. J. Proteome Res. 14,
457–466. doi: 10.1021/pr500852p
Hincz, P., Wilczynski, J., Kozarzewski, M., and Szaflik, K. (2002). Two-step test: the
combined use of fetal fibronectin and sonographic examination of the uterine
cervix for prediction of preterm delivery in symptomatic patients. Acta Obstet.
Gynecol. Scand. 81, 58–63. doi: 10.1034/j.1600-0412.2002.810111.x
Holst, D., and Garnier, Y. (2008). Preterm birth and inflammation - The role of
genetic polymorphisms. Eur. J. Obstet. Gynecol. Reprod. Biol. 141, 3–9. doi:
10.1016/j.ejogrb.2008.07.020
Holst, R. M., Mattsby-Baltzer, I., Wennerholm, U. B., Hagberg, H., and Jacobsson,
B. (2005). Interleukin-6 and interleukin-8 in cervical fluid in a population
of Swedish women in preterm labor: relationship to microbial invasion
of the amniotic fluid, intra-amniotic inflammation, and preterm delivery.
Acta Obstet. Gynecol. Scand. 84, 551–557. doi: 10.1111/j.0001-6349.2005.
00708.x
Honest, H., Bachamann, L. M., Gupta, J. K., Kleijnen, J., and Khan, K.
S. (2002). Accuracy of cervicovaginal fetal fibronectin test in predicting
risk of spontaneous preterm birth: systematic review. BMJ 325, 301. doi:
10.1136/bmj.325.7359.301
Honest, H., Bachmann, L. M., Coomarasamy, A., Gupta, J. K., Kleijnen, J., and
Khan, K. S. (2003). Accuracy of cervical transvaginal sonography in predicting
preterm birth: a systematic review. Ultrasound Obstet. Gynecol. 22, 305–322.
doi: 10.1002/uog.202
Houser, B. (2012). Bio-Rad’s Bio-Plex(R) suspension array system, xMAP
technology overview. Arch. Physiol. Biochem. 118, 192–196. doi:
10.3109/13813455.2012.705301
Iams, J. D. (2014). Identification of candidates for progesterone:
why, who, how, and when? Obstet. Gynecol. 123, 1317–1326. doi:
10.1097/AOG.0000000000000276
Iams, J. D., Goldenberg, R. L., Meis, P. J., Mercer, B. M., Moawad, A., Das, A.,
et al. (1996). The length of the cervix and the risk of spontaneous premature
delivery. National Institute of Child Health and Human Development
Maternal Fetal Medicine Unit Network. N. Engl. J. Med. 334, 567–572. doi:
10.1056/NEJM199602293340904
Institute ofMedicine. (2007). Preterm Birth. Causes, Consequences, and Prevention.
Washington, DC: National Academies Press.
Jacobsson, B., Holst, R. M., Mattsby-Baltzer, I., Nikolaitchouk, N., Wennerholm,
U. B., and Hagberg, H. (2003). Interleukin-18 in cervical mucus and amniotic
fluid: relationship to microbial invasion of the amniotic fluid, intra-amniotic
inflammation and preterm delivery. BJOG 110, 598–603. doi: 10.1046/j.1471-
0528.2003.02445.x
Johnson, S., Fawke, J., Hennessy, E., Rowell, V., Thomas, S., Wolke, D., et al.
(2009). Neurodevelopmental disability through 11 years of age in children
born before 26 weeks of gestation. Pediatrics 124, e249–e57. doi: 10.1542/peds.
2008-3743
Kekki, M., Kurki, T., Kärkkäinen, T., Hiilesmaa, V., Paavonen, J., and Rutanen, E.
M. (2001). Insulin-like growth factor-binding protein-1 in cervical secretion as
a predictor of preterm delivery. Acta Obstet. Gynecol. Scand. 80, 546–551. doi:
10.1080/j.1600-0412.2001.080006546.x
Kendal-Wright, C. E. (2007). Stretching, mechanotransduction, and
proinflammatory cytokines in the fetal membranes. Reprod. Sci. 14, 35–41. doi:
10.1177/1933719107310763
Khambay, H., Bolt, L. A., Chandiramani, M., De Greeff, A., Filmer, J. E., and
Shennan, A. H. (2012). The Actim Partus test to predict pre-term birth
in asymptomatic high-risk women. J. Obstet. Gynaecol. 32, 132–134. doi:
10.3109/01443615.2011.637649
Kishida, T., Yamada, H., Furuta, I., Kobayashi, N., Hirayama, E. K., Ebina,
Y., et al. (2003). Increased levels of interleukin-6 in cervical secretions and
assessment of the uterine cervix by transvaginal ultrasonography predict
preterm premature rupture of the membranes. Fetal Diagn. Ther. 18, 98–104.
doi: 10.1159/000068069
Klein, L. L., Jonscher, K. R., Heerwagen, M. J., Gibbs, R. S., and McManaman,
J. L. (2008). Shotgun proteomic analysis of vaginal fluid from women in late
pregnancy. Reprod. Sci. 15, 263–273. doi: 10.1177/1933719107311189
Frontiers in Physiology | www.frontiersin.org 14 May 2015 | Volume 6 | Article 151
Heng et al. Biomarkers of term and preterm birth
Kloeck, F. K., and Jung, H. (1973). In vitro release of prostaglandins from the
human myometrium under the influence of stretching. Am. J. Obstet. Gynecol.
115, 1066–1069.
Koistinen, R., Angervo, M., Leinonen, P., Hakala, T., and Seppälä, M. (1993).
Phosphorylation of insulin-like growth factor-binding protein-1 increases in
human amniotic fluid and decidua from early to late pregnancy. Clin. Chim.
Acta 215, 189–199. doi: 10.1016/0009-8981(93)90125-N
Krupa, F. G., Faltin, D., Cecatti, J. G., Surita, F. G., and Souza, J. P.
(2006). Predictors of preterm birth. Int. J. Gynaecol. Obstet. 94, 5–11. doi:
10.1016/j.ijgo.2006.03.022
Kuehn, B. M. (2012). Center takes broader look at preterm birth. JAMA 308, 2448.
doi: 10.1001/jama.2012.90690
Lauridsen, A., Vestergaard, P., and Nexo, E. (2001). Mean serum concentration
of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in
women. Clin. Chem. 47, 753–756.
Ledingham, M. A., Thomson, A. J., Jordan, F., Young, A., Crawford, M., and
Norman, J. E. (2001). Cell adhesion molecule expression in the cervix and
myometrium during pregnancy and parturition. Obstet. Gynecol. 97, 235–242.
doi: 10.1016/S0029-7844(00)01126-1
Ledingham, M. A., Thomson, A. J., Young, A., Macara, L. M., Greer, I. A., and
Norman, J. E. (2000). Changes in the expression of nitric oxide synthase in the
human uterine cervix during pregnancy and parturition.Mol. Hum. Reprod. 6,
1041–1048. doi: 10.1093/molehr/6.11.1041
Leitich, H. (2005). Secondary predictors of preterm labour. BJOG 112, 48–50. doi:
10.1111/j.1471-0528.2005.00584.x
Leitich, H., Brunbauer, M., Kaider, A., Egarter, C., and Husslein, P. (1999a).
Cervical length and dilatation of the internal cervical os detected by vaginal
ultrasonography as markers for preterm delivery: a systematic review. Am. J.
Obstet. Gynecol. 181, 1465–1472.
Leitich, H., Egarter, C., Kaider, A., Hohlagschwandtner, M., Berghammer, P., and
Husslein, P. (1999b). Cervicovaginal fetal fibronectin as a marker for preterm
delivery: a meta-analysis. Am. J. Obstet. Gynecol. 180, 1169–1176.
Lequin, R. M. (2005). Enzyme immunoassay (EIA)/enzyme-linked
immunosorbent assay (ELISA). Clin. Chem. 51, 2415–2418. doi:
10.1373/clinchem.2005.051532
Liggins, G. C. (1989). “Cervical ripening as an inflammatory reaction,” in The
Cervix in Pregnancy and Labour, eds D. A. Ellwood, A. B. M. Anderson, and
M. P. Embrey (Edinburgh: Churchill-Livingstone), 1–9.
Liong, S., Di Quinzio, M. K., Fleming, G., Permezel, M., and Georgiou, H. M.
(2013c). Is vitamin D binding protein a novel predictor of labour? PLoS ONE
8:e76490. doi: 10.1371/journal.pone.0076490
Liong, S., Di Quinzio, M. K., Fleming, G., Permezel, M., Rice, G. E., and Georgiou,
H. M. (2013a). Prediction of spontaneous preterm labour in at-risk pregnant
women. Reproduction 146, 335–345. doi: 10.1530/REP-13-0175
Liong, S., Di Quinzio, M. K., Fleming, G., Permezel, M., Rice, G. E., and Georgiou,
H. M. (2015). New biomarkers for the prediction of spontaneous preterm
labour in symptomatic pregnant women: a comparison with fetal fibronectin.
BJOG 122, 370–379. doi: 10.1111/1471-0528.12993
Liong, S., Di Quinzio, M. K., Heng, Y. J., Fleming, G., Permezel, M., Rice, G. E.,
et al. (2013b). Proteomic analysis of human cervicovaginal fluid collected before
preterm premature rupture of the fetal membranes. Reproduction 145, 137–147.
doi: 10.1530/REP-12-0264
Lo, J. O., Reddy, A. P., Wilmarth, P. A., Roberts, V. H., Kinhnarath, A., Snyder, J.,
et al. (2014). Proteomic analysis of cervical vaginal fluid proteins among women
in recurrent preterm labor. J. Matern. Fetal Neonatal Med. 27, 1183–1188. doi:
10.3109/14767058.2013.852172
Lockwood, C. J. (2003). Testing for risk of preterm delivery. Clin. Lab. Med. 23,
345–360. doi: 10.1016/S0272-2712(03)00029-5
Lockwood, C. J., Senyei, A. E., Dische, M. R., Casal, D., Shah, K. D., Thung,
S. N., et al. (1991). Fetal fibronectin in cervical and vaginal secretions
as a predictor of preterm delivery. N. Engl. J. Med. 325, 669–674. doi:
10.1056/NEJM199109053251001
Lorenz, J. (2001). The outcome of extreme prematurity. Semin. Perinatol. 25,
348–359. doi: 10.1053/sper.2001.27164
Loudon, J. A., Sooranna, S. R., Bennett, P. R., and Johnson, M. R. (2004).
Mechanical stretch of human uterine smooth muscle cells increases IL-8
mRNA expression and peptide synthesis.Mol. Hum. Reprod. 10, 895–899. doi:
10.1093/molehr/gah112
Ludmir, J., and Sehdev, H. M. (2000). Anatomy and physiology of the uterine
cervix. Clin. Obstet. Gynecol. 43, 433–439. doi: 10.1097/00003081-200009000-
00003
Lyall, F., Lye, S., Teoh, T., Cousins, F., Milligan, G., and Robson, S. (2002).
Expression of Gsalpha, connexin-43, connexin-26, and EP1, 3, and 4 receptors
in myometrium of prelabor singleton versus multiple gestations and the effects
of mechanical stretch and steroids on Gsalpha. J. Soc. Gynecol. Investig. 9,
299–307. doi: 10.1016/S1071-5576(02)00175-2
Lyndon, A. (2006). Preterm labor and birth: where are we now? J. Perinat. Neonatal
Nurs. 20, 82–84. doi: 10.1097/00005237-200601000-00024
Maehara, K., Kanayama, N., Maradny, E. E., Uezato, T., Fujita, M., and Terao,
T. (1996). Mechanical stretching induces interleukin-8 gene expression in
fetal membranes: a possible role for the initiation of human parturition. Eur.
J. Obstet. Gynecol. Reprod. Biol. 70, 191–196. doi: 10.1016/S0301-2115(95)
02602-9
Mandy, F. F., Nakamura, T., Bergeron, M., and Sekiguchi, K. (2001). Overview
and application of suspension array technology. Clin. Lab. Med. 21,
713–729.
Mangham, L. J., Petrou, S., Doyle, L. W., Draper, E. S., and Marlow, N. (2009). The
cost of preterm birth throughout childhood in England and Wales. Pediatrics
123, e312–e327. doi: 10.1542/peds.2008-1827
Maradny, E. E., Kanayama, N., Halim, A., Maehara, K., and Terao, T. (1996).
Stretching of fetal membranes increases the concentration of interleukin-8 and
collagenase activity. Am. J. Obstet. Gynecol. 174, 843–849. doi: 10.1016/S0002-
9378(96)70311-3
March of Dimes Foundation. (2009). March of Dimes White Paper on Preterm
Births: The Global and Regional Toll. White Plains, NY.
Marko-Varga, G., Lindberg, H., Löfdahl, C. G., Jönsson, P., Hansson, L., Dahlbäck,
M., et al. (2005). Discovery of biomarker candidates within disease by
protein profiling: principles and concepts. J. Proteome Res. 4, 1200–1212. doi:
10.1021/pr050122w
Martin, J. A., Hamilton, B. E., and Osterman, M. J. (2012). Three decades of twin
births in the United States, 1980-2009. NCHS Data Brief 80, 1–8.
Martin, J. A., and Osterman, M. J. (2013). Preterm births - United States, 2006 and
2010.MMWR Surveill. Summ. 62, 136–138.
Martina, N. A., Kim, E., Chitkara, U., Wathen, N. C., Chard, T., and Giudice, L.
C. (1997). Gestational age-dependent expression of insulin-like growth factor-
binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic
cavities, maternal serum, and decidua suggests decidua as the primary source
of IGFBP-1 in these fluids during early pregnancy. J. Clin. Endocrinol. Metab.
82, 1894–1898. doi: 10.1210/jc.82.6.1894
Matrisian, L. M. (1992). The matrix-degrading metalloproteinases. Bioessays 14,
455–463. doi: 10.1002/bies.950140705
McGregor, J. A., Allen, K. G., Harris, M. A., Reece, M., Wheeler, M., French, J.
I., et al. (2001). The omega-3 story: nutritional prevention of preterm birth
and other adverse pregnancy outcomes. Obstet. Gynecol. Surv. 56(Suppl. 1),
S1–S13.
Menon, R., and Fortunato, S. J. (2004). The role of matrix degrading enzymes and
apoptosis in rupture of membranes. J. Soc. Gynecol. Investig. 11, 427–437. doi:
10.1016/j.jsgi.2004.04.001
Menon, R., Lombardi, S. J., and Fortunato, S. J. (2002). TNF-alpha
promotes caspase activation and apoptosis in human fetal membranes.
J. Assist. Reprod. Genet. 19, 201–204. doi: 10.1023/A:10148981
30008
Menon, R., Torloni, M. R., Voltolini, C., Torricelli, M., Merialdi, M., Betrán,
A., et al. (2011). Biomarkers of spontaneous preterm birth: an overview
of the literature in the last four decades. Reprod. Sci. 18, 1046–1070. doi:
10.1177/1933719111415548
Mercer, B. M., Goldenberg, R. L., Moawad, A. H., Meis, P. J., Iams, J. D., Das, A.
F., et al. (1999). The preterm prediction study: effect of gestational age and
cause of preterm birth on subsequent obstetric outcome. National Institute
of Child Health and Human Development Maternal-Fetal Medicine Units
Network. Am. J. Obstet. Gynecol. 181(Pt 1), 1216–1221. doi: 10.1016/S0002-
9378(99)70111-0
Mercer, B. M., Moretti, M. L., Prevost, R. R., and Sibai, B. M. (1992). Erythromycin
therapy in preterm premature rupture of the membranes: a prospective,
randomized trial of 220 patients. Am. J. Obstet. Gynecol. 166, 794–802. doi:
10.1016/0002-9378(92)91336-9
Frontiers in Physiology | www.frontiersin.org 15 May 2015 | Volume 6 | Article 151
Heng et al. Biomarkers of term and preterm birth
Mesiano, S., Chan, E. C., Fitter, J. T., Kwek, K., Yeo, G., and Smith, R. (2002).
Progesterone withdrawal and estrogen activation in human parturition are
coordinated by progesterone receptor A expression in the myometrium. J. Clin.
Endocrinol. Metab. 87, 2924–2930. doi: 10.1210/jcem.87.6.8609
Michaels, J. E., Dasari, S., Pereira, L., Reddy, A. P., Lapidus, J. A., Lu, X.,
et al. (2007). Comprehensive proteomic analysis of the human amniotic fluid
proteome: gestational age-dependent changes. J. Proteome Res. 6, 1277–1285.
doi: 10.1021/pr060543t
Mitchell, M. D., Romero, R. J., Edwin, S. S., and Trautman, M. S. (1995).
Prostaglandins and parturition. Reprod. Fertil. Dev. 7, 623–632. doi:
10.1071/RD9950623
Monti, M., Orrù, S., Pagnozzi, D., and Pucci, P. (2005). Functional proteomics.
Clin. Chim. Acta 357, 140–150. doi: 10.1016/j.cccn.2005.03.019
Moore, R. M., Lundgren, D. W., Silver, R. J., and Moore, J. J. (2002).
Lactosylceramide-induced apoptosis in primary amnion cells and amnion-
derived WISH cells. J. Soc. Gynecol. Investig. 9, 282–289. doi: 10.1016/S1071-
5576(02)00172-7
Moore, R. M., Mansour, J. M., Redline, R. W., Mercer, B. M., and Moore,
J. J. (2006). The physiology of fetal membrane rupture: insight gained
from the determination of physical properties. Placenta 27, 1037–1051. doi:
10.1016/j.placenta.2006.01.002
Moore, R. M., Silver, R. J., and Moore, J. J. (2003). Physiological apoptotic agents
have different effects upon human amnion epithelial and mesenchymal cells.
Placenta 24, 173–180. doi: 10.1053/plac.2002.0886
Moster, D., Lie, R. T., and Markestad, T. (2008). Long-term medical and
social consequences of preterm birth. N. Engl. J. Med. 359, 262–273. doi:
10.1056/NEJMoa0706475
Moutquin, J. M. (2003). Classification and heterogeneity of preterm birth. BJOG
110(Suppl. 20), 30–33. doi: 10.1046/j.1471-0528.2003.00021.x
Myers, D. A., and Nathanielsz, P. W. (1993). Biologic basis of term and preterm
labor. Clin. Perinatol. 20, 9–28.
Nakai, A., Taniuchi, Y., Miyake, H., Nakai, M., Yokota, A., and Takeshita, T. (2005).
Increased level of granulocyte elastase in cervical secretion is an independent
predictive factor for preterm delivery. Gynecol. Obstet. Invest. 60, 87–91. doi:
10.1159/000084839
Nilsson, S., Ramström, M., Palmblad, M., Axelsson, O., and Bergquist, J.
(2004). Explorative study of the protein composition of amniotic fluid
by liquid chromatography electrospray ionization Fourier transform ion
cyclotron resonance mass spectrometry. J. Proteome Res. 3, 884–889. doi:
10.1021/pr0499545
Nishihara, S., Someya, A., Yonemoto, H., Ota, A., Itoh, S., Nagaoka, I., et al. (2008).
Evaluation of the expression and enzyme activity of matrix metalloproteinase-
7 in fetal membranes during premature rupture of membranes at term in
humans. Reprod. Sci. 15, 156–165. doi: 10.1177/1933719107310308
Norwitz, E. R., Robinson, J. N., and Challis, J. R. (1999). The control of labor. N.
Engl. J. Med. 341, 660–666. doi: 10.1056/NEJM199908263410906
Nuutila, M., Hiilesmaa, V., Kärkkäinen, T., Ylikorkala, O., and Rutanen, E. M.
(1999). Phosphorylated isoforms of insulin-like growth factor binding protein-
1 in the cervix as a predictor of cervical ripeness. Obstet. Gynecol. 94, 243–249.
doi: 10.1016/S0029-7844(99)00321-X
Okitsu, O., Mimura, T., Nakayama, T., and Aono, T. (1992). Early prediction of
preterm delivery by transvaginal ultrasonography. Ultrasound Obstet. Gynecol.
2, 402–409. doi: 10.1046/j.1469-0705.1992.02060402.x
Osman, I., Young, A., Jordan, F., Greer, I. A., and Norman, J. E. (2006). Leukocyte
density and proinflammatory mediator expression in regional human fetal
membranes and decidua before and during labor at term. J. Soc. Gynecol.
Investig. 13, 97–103. doi: 10.1016/j.jsgi.2005.12.002
Oyelese, Y., and Ananth, C. V. (2006). Placental abruption. Obstet. Gynecol. 108,
1005–1016. doi: 10.1097/01.AOG.0000239439.04364.9a
Park, S. J., Yoon, W. G., Song, J. S., Jung, H. S., Kim, C. J., Oh, S. Y., et al.
(2006). Proteome analysis of human amnion and amniotic fluid by two-
dimensional electrophoresis and matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry. Proteomics 6, 349–363. doi: 10.1002/pmic.
200500084
Paternoster, D. M., Muresan, D., Vitulo, A., Serena, A., Battagliarin, G.,
Dell’avanzo, M., et al. (2007). Cervical phIGFBP-1 in the evaluation of the
risk of preterm delivery. Acta Obstet. Gynecol. Scand. 86, 151–155. doi:
10.1080/00016340600935730
Pennington, S. R., Wilkins, M. R., Hochstrasser, D. F., and Dunn, M. J. (1997).
Proteome analysis: from protein characterization to biological function. Trends
Cell Biol. 7, 168–173. doi: 10.1016/S0962-8924(97)01033-7
Pereira, L., Reddy, A. P., Alexander, A. L., Lu, X., Lapidus, J. A., Gravett, M. G.,
et al. (2010). Insights into the multifactorial nature of preterm birth: proteomic
profiling of the maternal serum glycoproteome and maternal serum peptidome
among women in preterm labor. Am. J. Obstet. Gynecol. 202, 555.e1–555.e10.
doi: 10.1016/j.ajog.2010.02.048
Pereira, L., Reddy, A. P., Jacob, T., Thomas, A., Schneider, K. A., Dasari, S., et al.
(2007). Identification of novel protein biomarkers of preterm birth in human
cervical-vaginal fluid. J. Proteome Res. 6, 1269–1276. doi: 10.1021/pr0605421
Petrou, S. (2005). The economic consequences of preterm birth during the first 10
years of life. BJOG 112, 10–15. doi: 10.1111/j.1471-0528.2005.00577.x
Pociot, F., Molvig, J., Wogensen, L., Worsaae, H., and Nerup, J. (1992). A TaqI
polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with
IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 22, 396–402. doi: 10.1111/j.1365-
2362.1992.tb01480.x
Raio, L., Ghezzi, F., Di Naro, E., Gomez, R., and Luscher, K. P. (1997). Duration of
pregnancy after carbon dioxide laser conization of the cervix: influence of cone
height. Obstet. Gynecol. 90, 978–982. doi: 10.1016/S0029-7844(97)00489-4
Ramsey, P. S., and Andrews, W. W. (2003). Biochemical predictors of preterm
labor: fetal fibronectin and salivary estriol. Clin. Perinatol. 30, 701–733. doi:
10.1016/S0095-5108(03)00109-X
Rauk, P. N., and Chiao, J. P. (2000). Interleukin-1 stimulates human uterine
prostaglandin production through induction of cyclooxygenase-2 expression.
Am. J. Reprod. Immunol. 43, 152–159. doi: 10.1111/j.8755-8920.2000.430304.x
Rechberger, T., and Woessner, J. F. Jr. (1993). Collagenase, its inhibitors, and
decorin in the lower uterine segment in pregnant women. Am. J. Obstet.
Gynecol. 168, 1598–1603. doi: 10.1016/S0002-9378(11)90804-7
Resnik, R. (2005). Issues in the management of preterm labor. J. Obstet. Gynaecol.
Res. 31, 354–358. doi: 10.1111/j.1447-0756.2005.00302.x
Reti, N. G., Lappas, M., Riley, C., Wlodek, M. E., Permezel, M., Walker, S., et al.
(2007). Why do membranes rupture at term? Evidence of increased cellular
apoptosis in the supracervical fetal membranes. Am. J. Obstet. Gynecol. 196,
484. doi: 10.1016/j.ajog.2007.01.021
Rizzo, G., Capponi, A., Rinaldo, D., Tedeschi, D., Arduini, D., and Romanini, C.
(1996). Interleukin-6 concentrations in cervical secretions identify microbial
invasion of the amniotic cavity in patients with preterm labor and intact
membranes. Am. J. Obstet. Gynecol. 175(Pt 1), 812–817. doi: 10.1016/S0002-
9378(96)80004-4
Rizzo, G., Capponi, A., Vlachopoulou, A., Angelini, E., Grassi, C., and Romanini,
C. (1998). Ultrasonographic assessment of the uterine cervix and interleukin-8
concentrations in cervical secretions predict intrauterine infection in patients
with preterm labor and intact membranes. Ultrasound Obstet. Gynecol. 12,
86–92. doi: 10.1046/j.1469-0705.1998.12020086.x
Romero, R., Brody, D. T., Oyarzun, E., Mazor, M., Wu, Y. K., Hobbins, J. C.,
et al. (1989). Infection and labor. III. Interleukin-1: a signal for the onset of
parturition. Am. J. Obstet. Gynecol. 160(Pt 1), 1117–1123. doi: 10.1016/0002-
9378(89)90172-5
Romero, R., Kusanovic, J. P., Gotsch, F., Erez, O., Vaisbuch, E., Mazaki-Tovi, S.,
et al. (2010). Isobaric labeling and tandemmass spectrometry: a novel approach
for profiling and quantifying proteins differentially expressed in amniotic fluid
in preterm labor with and without intra-amniotic infection/inflammation.
J. Matern. Fetal Neonatal Med. 23, 261–280. doi: 10.3109/14767050903
067386
Romero, R., Munoz, H., Gomez, R., Parra, M., Polanco, M., Valverde, V.,
et al. (1996). Increase in prostaglandin bioavailability precedes the onset of
human parturition. Prostaglandins Leukot. Essent. Fatty Acids 54, 187–191. doi:
10.1016/S0952-3278(96)90015-0
Rüetschi, U., Rosén, A., Karlsson, G., Zetterberg, H., Rymo, L., Hagberg, H., et al.
(2005). Proteomic analysis using protein chips to detect biomarkers in cervical
and amniotic fluid in women with intra-amniotic inflammation. J. Proteome
Res. 4, 2236–2242. doi: 10.1021/pr050139e
Rutanen, E. M., Karkkainen, T. H., Lehtovirta, J., Uotila, J. T., Hinkula, M.
K., and Hartikainen, A. L. (1996). Evaluation of a rapid strip test for
insulin-like growth factor binding protein-1 in the diagnosis of ruptured
fetal membranes. Clin. Chim. Acta 253, 91–101. doi: 10.1016/0009-8981(96)
80001-E
Frontiers in Physiology | www.frontiersin.org 16 May 2015 | Volume 6 | Article 151
Heng et al. Biomarkers of term and preterm birth
Rutanen, E. M., Koistinen, R., Wahlström, T., Bohn, H., Ranta, T., and Seppälä, M.
(1985). Synthesis of placental protein 12 by human decidua. Endocrinology 116,
1304–1309. doi: 10.1210/endo-116-4-1304
Sadovsky, Y., and Friedman, S. A. (1992). Fetal fibronectin and preterm labor. N.
Engl. J. Med. 326, 709.
Sanchez-Ramos, L., Delke, I., Zamora, J., and Kaunitz, A. M. (2009).
Fetal fibronectin as a short-term predictor of preterm birth in
symptomatic patients: a meta-analysis. Obstet. Gynecol. 114, 631–640.
doi: 10.1097/AOG.0b013e3181b47217
Sanchez-Ramos, L., Mentel, C., Bertholf, R., Kaunitz, A. M., Delke, I., and Loge,
C. (2003). Human chorionic gonadotropin in cervicovaginal secretions as
a predictor of preterm delivery. Int. J. Gynaecol. Obstet. 83, 151–157. doi:
10.1016/S0020-7292(03)00273-X
Santoni, V., Molloy, M., and Rabilloud, T. (2000). Membrane proteins and
proteomics: un amour impossible? Electrophoresis 21, 1054–1070. doi:
10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.0.CO;2-8
Santtila, S., Savinainen, K., and Hurme, M. (1998). Presence of IL-1RA allele 2
(IL1RN*2) is associated with enhanced IL-1beta production. Scand. J. Immunol.
47, 195–198. doi: 10.1046/j.1365-3083.1998.00300.x
Schmitz, T., Maillard, F., Bessard-Bacquaert, S., Kayem, G., Fulla, Y., Cabrol,
D., et al. (2006). Selective use of fetal fibronectin detection after cervical
length measurement to predict spontaneous preterm delivery in women with
preterm labor. Am. J. Obstet. Gynecol. 194, 138–143. doi: 10.1016/j.ajog.2005.
05.074
Shah, S. J., Yu, K. H., Sangar, V., Parry, S. I., and Blair, I. A. (2009). Identification
and quantification of preterm birth biomarkers in human cervicovaginal fluid
by liquid chromatography/tandem mass spectrometry. J. Proteome Res. 8,
2407–2417. doi: 10.1021/pr8010342
Shankar, R., Gude, N., Cullinane, F., Brennecke, S., Purcell, A. W., and Moses, E.
K. (2005). An emerging role for comprehensive proteome analysis in human
pregnancy research. Reproduction 129, 685–696. doi: 10.1530/rep.1.00524
Shaw, J. L., Smith, C. R., and Diamandis, E. P. (2007). Proteomic analysis of human
cervico-vaginal fluid. J. Proteome Res. 6, 2859–2865. doi: 10.1021/pr0701658
Shimoya, K., Hashimoto, K., Shimizu, T., Saji, F., and Murata, Y. (1998). Effect
of sexual intercourse on fetal fibronectin concentration in cervicovaginal
secretions. Am. J. Obstet. Gynecol. 179, 255–256. doi: 10.1016/S0002-
9378(98)70280-7
Sibille, Y., Lwebuga-Mukasa, J. S., Polomski, L., Merrill, W. W., Ingbar, D. H., and
Gee, J. B. (1986). An in vitromodel for polymorphonuclear-leukocyte-induced
injury to an extracellular matrix. Relative contribution of oxidants and elastase
to fibronectin release from amnionic membranes. Am. Rev. Respir. Dis. 134,
134–140.
Skannal, D. G., Brockman, D. E., Eis, A. L. W., Xue, S., Siddiqi, T. A., and Myatt, L.
(1997). Changes in activity of cytosolic phospholipase A2 in human amnion
at parturition. Am. J. Obstet. Gynecol. 177, 179–184. doi: 10.1016/S0002-
9378(97)70459-9
Slater, D. M., Astle, S., Bennett, P. R., and Thornton, S. (2004). Labour is associated
with increased expression of type-IIA secretory phospholipase A2 but not type-
IV cytosolic phospholipase A2 in human myometrium.Mol. Hum. Reprod. 10,
799–805. doi: 10.1093/molehr/gah103
St. John, E. B., Nelson, K. G., Cliver, S. P., Bishnoi, R. R., and Goldenberg, R.
L. (2000). Cost of neonatal care according to gestational age at birth and
survival status. Am. J. Obstet. Gynecol. 182(Pt 1), 170–175. doi: 10.1016/S0002-
9378(00)70509-6
Steer, P. (2006). The epidemiology of preterm labour - why have advances
not equated to reduced incidence? BJOG 113, 1–3. doi: 10.1111/j.1471-
0528.2006.01116.x
Tambor, V., Kacerovsky, M., Andrys, C., Musilova, I., Hornychova, H., Pliskova,
L., et al. (2012). Amniotic fluid cathelicidin in PPROM pregnancies: from
proteomic discovery to assessing its potential in inflammatory complications
diagnosis. PLoS ONE 7:e41164. doi: 10.1371/journal.pone.0041164
Tanaka, Y., Narahara, H., Takai, N., Yoshimatsu, J., Anai, T., and Miyakawa,
I. (1998). Interleukin-1beta and interleukin-8 in cervicovaginal fluid during
pregnancy. Am. J. Obstet. Gynecol. 179(Pt 1), 644–649. doi: 10.1016/S0002-
9378(98)70058-4
Tang, L. J., De Seta, F., Odreman, F., Venge, P., Piva, C., Guaschino, S., et al.
(2007). Proteomic analysis of human cervical-vaginal fluids. J. Proteome Res.
6, 2874–2883. doi: 10.1021/pr0700899
Tanir, H. M., Sener, T., and Yildiz, Z. (2009). Cervical phosphorylated insulin-
like growth factor binding protein-1 for the prediction of preterm delivery in
symptomatic cases with intact membranes. J. Obstet. Gynaecol. Res. 35, 66–72.
doi: 10.1111/j.1447-0756.2008.00833.x
Taylor, B. D., Holzman, C. B., Fichorova, R. N., Tian, Y., Jones, N. M., Fu, W., et al.
(2013). Inflammation biomarkers in vaginal fluid and preterm delivery. Hum.
Reprod. 28, 942–952. doi: 10.1093/humrep/det019
Terzidou, V., Sooranna, S. R., Kim, L. U., Thornton, S., Bennett, P. R., and Johnson,
M. R. (2005). Mechanical stretch up-regulates the human oxytocin receptor in
primary human uterine myocytes. J. Clin. Endocrinol. Metab. 90, 237–246. doi:
10.1210/jc.2004-0277
Thomson, A. J., Telfer, J. F., Young, A., Campbell, S., Stewart, C. J., Cameron, I. T.,
et al. (1999). Leukocytes infiltrate the myometrium during human parturition:
further evidence that labour is an inflammatory process. Hum. Reprod. 14,
229–236. doi: 10.1093/humrep/14.1.229
Timmons, B. C., andMahendroo, M. (2007). Processes regulating cervical ripening
differ from cervical dilation and postpartum repair: insights from gene
expression studies. Reprod. Sci. 14, 53–62. doi: 10.1177/1933719107309587
Ting, H. S., Chin, P. S., Yeo, G. S., and Kwek, K. (2007). Comparison of bedside
test kits for prediction of preterm delivery: phosphorylated insulin-like growth
factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann. Acad.
Med. Singap. 36, 399–402.
Turton, P., Neilson, J. P., Quenby, S., Burdyga, T., and Wray, S. (2009). A short
review of twin pregnancy and how oxytocin receptor expression may differ
in multiple pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 144(Suppl 1),
S40–S44. doi: 10.1016/j.ejogrb.2009.02.011
Ulmsten, U., Andersson, K. E., and Wingerup, L. (1980). Treatment of premature
labor with the calcium antagonist nifedipine. Arch. Gynecol. 229, 1–5. doi:
10.1007/BF02109822
Unlu, M., Morgan, M. E., and Minden, J. S. (1997). Difference gel electrophoresis:
a single gel method for detecting changes in protein extracts. Electrophoresis 18,
2071–2077. doi: 10.1002/elps.1150181133
Vadillo-Ortega, F., González-Avila, G., Furth, E. E., Lei, H., Muschel, R. J.,
Stetler-Stevenson, W. G., et al. (1995). 92-kd type IV collagenase (matrix
metalloproteinase-9) activity in human amniochorion increases with labor.
Am. J. Pathol. 146, 148–156.
Vaisanen-Tommiska, M., Nuutila, M., Aittomaki, K., Hiilesmaa, V., and
Ylikorkala, O. (2003). Nitric oxide metabolites in cervical fluid during
pregnancy: further evidence for the role of cervical nitric oxide in cervical
ripening. Am. J. Obstet. Gynecol. 188, 779–785. doi: 10.1067/mob.2003.161
Vuadens, F., Benay, C., Crettaz, D., Gallot, D., Sapin, V., Schneider, P., et al. (2003).
Identification of biologic markers of the premature rupture of fetal membranes:
proteomic approach. Proteomics 3, 1521–1525. doi: 10.1002/pmic.200300455
Wang, T., Zhou, R., Zhang, L., Wang, Y., Song, C., Lin, W., et al. (2011). Proteins
in leaked amniotic fluid as biomarkers diagnostic for prelabor rupture of
membranes. Proteomics Clin. Appl. 5, 415–421. doi: 10.1002/prca.201000123
Wathen, N. C., Egembah, S., Campbell, D. J., Farkas, A., and Chard, T. (1993).
Levels of insulin-like growth factor-binding protein-1 increase rapidly in
amniotic fluid from 11 to 16 weeks of pregnancy. J. Endocrinol. 137, R1–R4.
doi: 10.1677/joe.0.137R001
Wei, S., Fraser, W., and Luo, Z. (2010). Inflammatory cytokines and spontaneous
preterm birth in asymptomatic women: a systematic review. Obstet. Gynecol.
116(Pt 1), 393–401. doi: 10.1097/AOG.0b013e3181e6dbc0
Westwood, M., Gibson, J. M., Davies, A. J., Young, R. J., and White, A. (1994).
The phosphorylation pattern of insulin-like growth factor-binding protein-1
in normal plasma is different from that in amniotic fluid and changes during
pregnancy. J. Clin. Endocrinol. Metab. 79, 1735–1741. doi: 10.1210/jc.79.6.1735
Woodworth, A., Moore, J., G’Sell, C., Verdoes, A., Snyder, J. A., Morris, L., et al.
(2007). Diagnostic accuracy of cervicovaginal interleukin-6 and interleukin-
6:albumin ratio as markers of preterm delivery. Clin. Chem. 53, 1534–1540. doi:
10.1373/clinchem.2007.084798
World Health Organisation. (2012). March of Dimes, PMNCH, Save the Children,
WHO. Born Too Soon: The Global Action Report on Preterm Birth. eds C. P.
Howson, M. V. Kinney, and J. E. Lawn (Geneva).
Xu, P., Alfaidy, N., and Challis, J. R. (2002). Expression ofmatrix metalloproteinase
(MMP)-2 and MMP-9 in human placenta and fetal membranes in relation
to preterm and term labor. J. Clin. Endocrinol. Metab. 87, 1353–1361. doi:
10.1210/jcem.87.3.8320
Frontiers in Physiology | www.frontiersin.org 17 May 2015 | Volume 6 | Article 151
Heng et al. Biomarkers of term and preterm birth
Yan, W. H., Apweiler, R., Balgley, B. M., Boontheung, P., Bundy, J. L., Cargile, B. J.,
et al. (2009). Systemic comparison of the human saliva and plasma proteomes.
Proteomics Clin. Appl. 3, 116–134. doi: 10.1002/prca.200800140
Yin, B., and Zhen, M. (1995). Lipid peroxidation in plasma and the activity of
superoxide dismutase (SOD) in pregnant women with premature rupture of
membrane. Zhonghua Yi Xue Za Zhi 75, 463-465, 509.
Yoshida, M., Sagawa, N., Itoh, H., Yura, S., Korita, D., Kakui, K., et al.
(2001). Nitric oxide increases matrix metalloproteinase-1 production in
human uterine cervical fibroblast cells. Mol. Hum. Reprod. 7, 979–985. doi:
10.1093/molehr/7.10.979
Young, I. R., Rice, G. E., Palliser, H. K., Ayhan, M., Dellios, N. L., and Hirst,
J. J. (2007). Identification of bactenecin-1 in cervicovaginal fluid by two-
dimensional electrophoresis in an ovine model of preterm labour. Proteomics
7, 281–288. doi: 10.1002/pmic.200500705
Zegels, G., Van Raemdonck, G. A., Coen, E. P., Tjalma, W. A., and Van
Ostade, X. W. (2009). Comprehensive proteomic analysis of human cervical-
vaginal fluid using colposcopy samples. Proteome Sci. 7:17. doi: 10.1186/1477-
5956-7-17
Zegels, G., Van Raemdonck, G. A., Tjalma, W. A., and Van Ostade, X. W. (2010).
Use of cervicovaginal fluid for the identification of biomarkers for pathologies
of the female genital tract. Proteome Sci. 8:63. doi: 10.1186/1477-5956-8-63
Zhang, J., and Savitz, D. A. (1992). Preterm birth subtypes among black and whites.
Epidemiology 3, 428–433. doi: 10.1097/00001648-199209000-00008
Zhou, S., Bailey, M. J., Dunn, M. J., Preedy, V. R., and Emery, P. W. (2005). A
quantitative investigation into the losses of proteins at different stages of a
two-dimensional gel electrophoresis procedure. Proteomics 5, 2739–2747. doi:
10.1002/pmic.200401178
Zürbig, P., Decramer, S., Dakna,M., Jantos, J., Good, D.M., Coon, J. J., et al. (2009).
The human urinary proteome reveals high similarity between kidney aging and
chronic kidney disease. Proteomics 9, 2108–2117. doi: 10.1002/pmic.200800560
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Heng, Liong, Permezel, Rice, Di Quinzio and Georgiou. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Physiology | www.frontiersin.org 18 May 2015 | Volume 6 | Article 151
